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Abstract
The effect of an in utero high fat diet on the expression of transcription 
factors and glucose sensing in the developing rat pancreas 
Introduction
A high fat diet (HFD) reduces beta-cell mass, impairs glucose signalling and is 
involved in the development of Type 2 diabetes. Malnutrition during gestation is 
hypothesized to irreversibly damage beta-cell development. The transcription 
factors Pdx-1 and Pax 4 are involved in islet cell development. Pdx-1 is reported 
to regulate expression of GLUT-2, glucokinase (GK) and the insulin gene.
Aims
The aim of this study is to investigate, in the neonatal and weanling rat, the effect 
of exposure to a HFD in utero and/or lactation on weight, glucose and insulin 
concentrations, islet cell development, pancreatic transcription factors and 
glucose sensing genes.
Methods
Neonatal and weanling rats were exposed to a maternal HFD for defined periods 
of gestation and/or lactation. After termination, pups were weighed and glucose 
and insulin concentrations determined. mRNA expression of Pdx-1, Pax 4, 
GLUT-2 and GK was quantified by LightCycler PCR. Pancreatic sections were 
immunostained for insulin and glucagon (islet cell development), and for Pdx-1, 
GLUT-2 and GK (beta-cell function) followed by image analysis.
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Results
Exposure to an in utero HFD throughout gestation resulted in hyperglycaemic 
pups with reduced beta-cell volume and number, Pdx-1 and GK 
immunoreactivity. In contrast the alpha-cell volume, number and size were 
augmented in neonates exposed to a HFD throughout gestation.
Most weanlings were hyperglycaemic and hypoinsulinaemic. In some weanlings, 
reduced beta-cell number and beta- and alpha-cell size was observed. Pdx-1 
mRNA was overexpressed in weanlings exposed to a maternal HFD for the final 
week of gestation or throughout both gestation and lactation, but reduced in 
those only exposed throughout lactation. Pax 4 mRNA was reduced in weanlings 
exposed to a maternal HFD for the first or final week of gestation, throughout 
gestation or throughout lactation. In most of the weanlings, GLUT-2 mRNA 
expression was reduced whereas immunoreactivity for GLUT-2 was increased. 
Both GK mRNA expression and immunoreactivity were reduced in most of the 
weanlings.
Conclusions
• Exposure to an in utero HFD throughout gestation induced 
hyperglycaemia in neonates. The reduced Pdx-1 expression appears to 
play a role in the compromised beta-cell development, and concomitant 
with the reduced GK levels, contributes to the hyperglycaemia in these 
neonates and may make them susceptible to beta-cell failure.
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In most weanlings exposed to a HFD in utero and/or during lactation the 
hyperglycaemia and hypoinsulinaemia suggest compromised beta-cell 
function. The GK mRNA expression and immunoreactivity were reduced 
thereby impairing glycolysis which would result in reduced insulin 
secretion contributing to the hyperglycaemia. Furthermore, beta-cell 
development is adversely affected by the HFD in some weanlings. This 
would contribute to reduced beta-cell function and may eventually result in 
beta-cell failure. GLUT-2 immunoreactivity was increased in some, 
suggesting a compensatory adaptative mechanism to restore glucose 
homeostasis.
A maternal HFD has adverse effects both in neonates and weanlings on 
beta-cell development, transcription factor and glucose sensing gene 
expression and induced hyperglycaemia and hypoinsulinaemia in some of 
the offspring. Ways to ameliorate the HFD-induced attenuation of key 
beta-cell genes to ensure normal beta-cell function are important for future 
research in Type 2 diabetes.
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Opsomming 
Inleiding
‘n Hoe vet diet (HVD) verminder beta-sel masse, glukose signale en speel ‘n rol 
in Tipe 2 diabetes. Die hipothese is dat wanvoeding gedurende swangerskap lei 
tot onomkeerbare betasel beskadiging. Die transkripsiefaktore Pdx-1 en Pax 4 
speel rolle in eilandselontwikkeling. Daar is bewyse dat Pdx-1 die uitdrukking van 
die GLUT-2, glucokinase (GK) en insulin gene reguleer.
Doelstelling
Die doel van hierdie studie is om, in die pasgebore en gespeende rot, die effek 
van ’n HVD in utero en/of laktasie op gewig, glukose en insulin konsentrasies, 
eilandselontwikkeling, pankreatiese transksripsiefaktore en op glukose- 
waarnemingsgene te ondersoek.
Metodes
Pasgebore en gespeende rotte is vir bepaalde periodes van gestasie en/of 
laktasie blootgestel aan ’n HVD van die moeder. Na terminase, is kleinjies 
geweeg en die glukose- en insulienkinsentrasies bepaal. mRNA uitdrukking van 
Pdx-1, Pax 4, GLUT-2 en GK is geoes met LightCycler PCR. Snitte van die 
pankreas is gekleur met insulien en glukagon (eilandsontwikkeling) en vir Pdx-1, 
GLUT-2 en GK (betaselfunksie) gevolg deur beeldanalise.
VI
Stellenbosch University http://scholar.sun.ac.za/
Resultate
Bloodstelling aan ’n in utero HVD regdeur gestasie het hiperglisemie versoorsaak 
in pasgebore rotte met verlaagde betasel volume en aantal, Pdx-1 en GK 
immunoreaktiwiteit. In teenstelling daarmee was die alfasel se volume, aantal en 
grootte verhoog in pasgebore rotte wat regdeur gestasie aan 'n HVD blootgestel 
was.
Meeste van die gespeende rotte was hiperglisemies en hipoinsulinemies. In 
sommige gespeende rotte, was daar ’n verlaging van betasel hoeveelheid en 
grootte en in alfasel groote. Oormatige uitdrukking van Pdx-1 mRNA het 
plaasgevind in speenlinge wat aan ’n HVD van die moeder vir die laaste week 
van gestasie of regdeur gestasie en laktasie blootgestel was, maar dit was 
verlaag in die speenlinge wat net tydens laktasie blootgestel was. Pax 4 mRNA 
was verlaag in speenlinge wat aan ’n HVD van die moeder blootgestel was vir 
die eerste of laaste week van gestasie, regdeur gestasie of regdeur laktasie. In 
meeste van die speenlinge is onder-uitdrukking van GLUT-2 mRNA, maar ’n 
verhoging van GLUT-2 immunoreaktiwiteit gevind. Beide GK mRNA uitdrukking 
en immunoreaktiwiteit was laer in meeste van die speenlinge.
Gevolgtrekkings
• Blootstelling aan ’n in utero HVD regdeur gestasie lei tot hiperglisemie in 
pasgebore rotte. Die verlaagde Pdx-1 immunoreaktiwiteit speel 
klaarblyklik ’n rol by die geaffekteerde betaselontwikkeling. Dit, saam met
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die verlaagde immunoreaktiwiteit vir GK, kan bydra tot die hiperglisemie in 
hierdie pasgebore rotte.
In die meeste van die speenlinge wat aan ’n HVD blootgestel was, dui die 
hiperglisemie en hipoinsulinemie op geaffekteerde betaselfunksie. Die GK 
mRNA uitdrukking en immunoreaktiwiteit is verlaag, wat weer glikolise 
benadeel, en dit sal lei tot verminderde insulienafskeiding wat bydra tot die 
hiperglisemie. Betaselontwikkeling word voorts negatief beinvloed deur 
die HVD, wat blyk uit die verlaagde aantal en grootte van betaselle. Dit sal 
bydra tot verminderde betaselfunksie. Dit kan uiteindelik tot 
betaselversaking lei. GLUT-2 immunoreaktiwiteit was verhoog in hierdie 
speenlinge, wat dui op ’n kompenserende aanpassingsmeganisme om 
glukose homeostase te herstel.
’n HVD van die moeder het ’n negatiewe uitwerking op 
betaselontwikkeling, transkripsiefaktor en glukosewaarneming 
geenuitdrukking in beide die pasgebore en gespeende rotte, en 
geinduseerde hiperglisemie en hipoinsulinemie in sommige kleintjies. Dis 
belangrik vir toekomstige Tipe 2 diabetes navorsing dat daar na gekyk 
moet word om die HVD-geinduseerde verlaging van sleutel betaselgene 
te verbeter vir optimale betaselfunksie.
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CHAPTER 1 
INTRODUCTION 
AND HISTORICAL
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1.1 Overview of Type 2 diabetes mellitus
The clinical hallmark of diabetes mellitus is chronic hyperglycaemia. According to 
WHO a random venous plasma glucose concentration that exceeds 11.1 mmol/l 
or a fasting value of >7.8 mmol/l establishes the diagnosis of diabetes. Diabetes 
can be subdivided into two main classifications: Type 1 diabetes, the more 
severe form characterized by the autoimmune destruction of pancreatic beta- 
cells and a young age of onset; and Type 2 diabetes, which accounts for 
approximately 90% of all diabetes cases and predominantly occurred in the 
middle-aged and elderly but is now occurring at a much younger age. Type 1 
diabetes can be distinguished from Type 2 diabetes by a sudden onset of severe 
hyperglycaemic symptoms, in the former, with marked weight loss, spontaneous 
sustained ketosis or ketonuria, an inadequate C-peptide response to stimulation 
by glucagon and by markers of autoimmune activity (1). Symptoms of Type 2 
diabetes include hunger, thirst, excessive urination and weight loss.
Type 2 diabetes is primarily associated with beta-cell failure and insulin 
resistance. Beta-cell failure can be defined as the reduced capacity of beta-cells 
to secrete sufficient insulin in response to glucose. Insulin resistance is the 
inability of insulin to exert its usual biological effects at circulating concentrations 
that are effective in normal subjects. Obesity is the most common cause of 
insulin resistance in children (2). A recent study has shown that insulin resistance 
deteriorates with increasing obesity in children and adolescents (3). A Type 2 
diabetes epidemic is arising in developing countries and their migrants, with an
1
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expected increase of up to 200 million people being affected worldwide by 2010. 
Diabetes is a major health problem, especially in developing countries with poor 
economies, as it causes high rates of morbidity and mortality and therefore has a 
great economic impact on national health systems. The prevalence of Type 2 
diabetes is low (<1%) in many developing societies such as rural Melanesians in 
Papua New Guinea (4), and significantly higher in certain population groups that 
have undergone rapid westernization, such as the Pimas and Nauruans in whom 
the incidence can be as high as 40-50% concomitant with an earlier age of onset 
(5;6). In South Africa, Type 2 diabetes is increasing in incidence particularly in 
migrants. The highest incidence of Type 2 diabetes is described in individuals 
who have moved from severe malnutrition and a traditional way of life to an 
urbanized setting. This has been demonstrated in Ethiopian Jews who migrated 
to Israel where the prevalence of Type 2 diabetes was 9% compared to an 
incidence of only 1-2% in Ethiopia (7). Similarly, the prevalence of Type 2 
diabetes is expected to increase significantly over the next decade in South 
Africa with its increasing urbanization, sedentary lifestyles, and wider variety of 
food choices with higher dietary fat contents.
The thrifty genotype hypothesis suggests that Type 2 diabetes susceptibility 
genes favour energy storage, perhaps by inducing insulin resistance selectively 
in the liver and skeletal muscle, resulting in raised insulin levels which would 
promote triglyceride deposition in fat (8). These thrifty genes confer survival in 
harsh conditions such as famine but could lead to obesity, insulin resistance and
2
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Type 2 diabetes in conditions of excessive availability of food, much of which is 
from unhealthy fast food outlets. This has been suggested to explain the 
emergence and spread of Type 2 diabetes in societies that adopt a westernized 
lifestyle (4).
3
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1.2 Pancreatic development
The pancreas is composed of the endocrine hormone-producing islets, the 
exocrine acini that produce various digestive enzymes (such as amylases, 
proteases, nucleases), and the ductal tree comprising the centroacinar cells, 
ductules and ducts that transport these enzymes into the intestine. The normal 
human adult pancreas is highly vascularized, richly innervated and contains 
about 1 million islets, which constitute 2% of the organ’s total weight. The main 
cell types are the beta-, alpha-, delta- and PP-cells that produce the hormones 
insulin, glucagon, somatostatin and pancreatic polypeptide, respectively, with the 
core of the islet containing the beta-cells and the remaining cell types dispersed 
in the periphery of the islets.
Pancreas organogenesis involves a sequential cascade of inductive events in 
association with the activation of specific transcription factors (9). During early 
embryogenesis, the pancreas arises from an evagination of the foregut to form a 
dorsal and then a ventral epithelial bud (9). Subsequently both of these buds 
proliferate to form multiple branches and fuse together to form a functional organ 
(9). The ontogenesis of the pancreas starts with the appearance of 
protodifferentiated epithelial cells, which form ductules from which both acinar 
and islet cells originate (10).
All islet cells are believed to originate from pluripotent progenitor cells both during 
development and later in life (11). Islet progenitor cells, which arise from the
4
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pancreatic ductal epithelium, undergo a series of cytodifferentiation steps that 
lead to the formation of mature islets (12). During embryogenesis in rodents, 
presumptive islet precursor cells are first observed about halfway through the 
gestational period. These cells proliferate, differentiate and then aggregate into 
mature islets which are not seen until later in gestation (13). New islets continue 
to form postnatally, but at a lower rate than during embryogenesis (13; 14). Islet 
progenitor cells are thought to reside within pancreatic ductal epithelium and 
serve as a reservoir for islet neogenesis (14). Hence it may be possible that they 
express molecular markers shared between both the foregut endoderm and the 
developing islet cells, that they express some of the transcription factors and 
other proteins that distinguish mature beta-cells, and that they are able to 
differentiate into islet hormone-expressing cells (15). Islet cell differentiation 
depends on multiple transcription factors that display highly restricted cell- 
specific expression patterns (16-18).
Histomorphometric studies have revealed that, during late fetal gestation (19-21) 
and early neonatal life (22;23), most new beta-cells are formed by neogenesis, a 
process by which endocrine cell buds develop from duct epithelium (10). In the 
rat, the various endocrine cell types appear independently during different times 
of gestation and both the size and number of islets continue to increase as the 
animal develops (10). There is continued growth of each islet cell population 
throughout the prenatal and postnatal development of the rat (21). On the final 
day of gestation, the arrangement of the islet cells in the neonate appears to be
5
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similar to the adult rat, with most of the growth occurring in the last 2-3 days 
before birth (21). The most abundant endocrine cell type at day 18 of gestation is 
reported to be the beta-cell (21). New beta-cells can be formed by either mitotic 
division of a pre-existing differentiated beta-cell (replication), or by differentiation 
from an undifferentiated precursor or stem cell (neogenesis) (24).
6
Stellenbosch University http://scholar.sun.ac.za/
1.3 In utero programming
The thrifty phenotype hypothesis states that malnutrition in utero causes beta-cell 
development to be irreversibly damaged during critical periods of foetal 
development (25). Epidemiological studies, using archival records of 
measurements related to human foetal growth, have shown strong statistical 
links between birth weight and/or maternal nutrition and Type 2 diabetes and the 
insulin resistance syndrome in adult life (25). It has been hypothesized that these 
associations involve adaptive alterations of foetal organogenesis in response to 
maternal nutrition (25). Foetal growth and development are determined primarily 
by the genetic potential of the foetus and this can be influenced by environmental 
factors such as the nutritional status of the mother and the capacity of the 
placenta to transport these nutrients to the foetus (26). Exposure to an in utero 
high fat diet (HFD) could programme the foetus metabolically for continued HFD 
consumption postnatally. Poor nutrition in utero, followed by normal or 
supranormal nutrition after birth could result in impaired growth of beta-cells and 
a predisposition of the individual to develop Type 2 diabetes later in life (25). This 
was supported by the finding that intrauterine low protein exposure, in rats, 
reduces pancreatic islet size, islet vascularization, number of beta-cells and 
insulin content (27;28).
An isocaloric diet, containing 8% instead of the recommended 20% protein 
required during pregnancy, leads to a profound impairment in the structural and 
functional development of the rat foetal endocrine pancreas, reduced foetal
7
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growth and a low birth weight (29). However, provision of a diet containing the 
normal protein content, from weaning to adulthood leads to recovery in insulin 
secretory capacity (29). A high energy/HFD led to a markedly lower insulin 
secretory response to glucose in previously protein malnourished rats (30). The 
transfer of rats that previously experienced sub-optimal protein nutrition, to a high 
energy/HFD was associated with a modest (18%) decline in the rate of glucose 
disappearance after intravenous glucose tolerance test (30). High fat feeding 
dramatically enhanced glucose-stimulated insulin secretion (GSIS) after 
intravenous glucose infusion in control rats, but not in rats previously maintained 
on a low protein (8%) diet (30). Impaired insulin secretion after protein 
malnutrition is exacerbated by a HFD, but this response is not linked to whole 
body insulin resistance (30). A recent study showed that newborn and weaned 
rats that were exposed to low protein diets had low body weights and high free 
fatty acid (FFA) levels (31). Islets of rats exposed to a low protein diet showed 
reduced GSIS in the presence of a high glucose concentration of 16.7 mmol/l 
(31).
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1.4 A HFD, obesity, insulin resistance and Type 2 diabetes
A HFD has been shown to be linked to the development of obesity, insulin 
resistance, and Type 2 diabetes and to impair the glucose-signalling system in 
the beta-cell thereby suppressing insulin secretion (32-34). A HFD in human 
subjects and nonhuman primates has been shown to induce impaired glucose 
tolerance, supporting the hypothesis that an increase in dietary fat intake could 
be associated with the development of Type 2 diabetes (35;36). Reduced beta­
cell volume has been reported in Vervet monkeys maintained on a HFD for 1.5 
years (37), and significantly high plasma LDL and raised glucagon levels and 
weight have been recorded in Vervet monkeys after 2.5 years of a HFD (38).
Obesity is characterized by increased body fat stores resulting from an 
imbalance between energy intake and energy expenditure. Increased adiposity is 
strongly correlated with Type 2 diabetes (39) and different fat depots have 
different effects on reducing insulin sensitivity, with intra-abdominal fat having a 
greater impact than peripheral fat (40;41). FFA from central depots have direct 
access, via the portal vein to the liver, where they enhance hepatic glucose 
production by increasing the rate of gluconeogenesis (42;43). Increased levels of 
FFA are also thought to contribute to insulin resistance via the Randle cycle (44).
This glucose-FFA cycle involves a reciprocal relationship between glucose and 
FFA oxidation. During states of excess FFA, FFA oxidation is increased and 
glucose oxidation reduced, thereby affecting glucose utilization (45). Other 
factors whereby excess fat may contribute to insulin resistance include increased
9
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production of tumor necrosis factor-a (46) and interleukin-6 (47), excess muscle 
triglyceride accumulation (48), elevated leptin levels (49) and the production of 
resistin (50).
A long-term (48 weeks) challenge of C57BL/6J mice with a HFD (58% fat on a 
caloric base compared with 11% in the control diet), led to hyperglycaemia, 
hyperinsulinaemia, hyperlipidaemia and hyperleptinaemia (51). These mice were 
also found to have increased beta-cell mass but reduced insulin mRNA 
expression and an intraperitoneal glucose tolerance test revealed marked 
impairment of glucose disposal (51). Therefore glucose intolerance after long­
term high fat feeding is accompanied by reduced cellular expression of insulin 
(51). A mechanism which may be involved in islet dysfunction is elevated levels 
of circulating FFA, which increase the beta-cell content of triglycerides, reduce 
insulin biosynthesis and secretion and induce apoptosis (52-54). The increase in 
beta-cell mass in HFD-fed mice suggests that it evolves as an adaptation to 
hyperlipidaemia and insulin resistance.
Although insulin resistance often accompanies obesity, glucose homeostasis is 
usually maintained by compensatory hypersecretion of insulin by the beta-cells 
(55;56). This hyperinsulinaemic state promotes lipogenesis, inhibits lipolysis and 
increases lipoprotein lipase (LPL) activity in adipose tissue (57;58), further 
aggravating the obese state. LPL catalyzes the hydrolysis of lipoprotein- 
associated triglycerides into fatty acids and glycerol. These FFA become
10
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available for local uptake (59), thereby increasing insulin resistance. Ultimately, 
in some individuals, beta-cells are unable to meet the demand for insulin 
production and secretion and hyperglycemia and Type 2 diabetes develop.
Pathophysiological events, that relate a HFD to Type 2 diabetes include obesity- 
induced alterations in glucose metabolism; insulin resistance induced by 
hyperglycemia, which results from elevations in FFA levels via the Randle cycle, 
and alterations in insulin action that arise from changes in plasma membrane 
fluidity because of their dietary fat composition (60). The Type 2 diabetes 
lipotoxicity hypothesis (52) states that peripheral insulin resistance and islet cell 
dysfunction result from increased triglycerides in the peripheral and islet tissue 
where, for example, lipid induced nitric oxide-mediated apoptosis of beta-cells 
has been demonstrated (54).
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1.5 An overview of the transcription factors involved in pancreatic 
development and beta-cell maintenance
Most new beta-cells are formed by neogenesis when endocrine cell buds 
develop from ductal epithelium during late gestation and early neonatal life 
(10;21;22). Factors that a HFD could affect are duct cell proliferation, budding or 
beta-cell differentiation. Cell differentiation depends on multiple transcription 
factors that display highly restricted cell-specific expression patterns. These 
transcription factors are required for the initiation of transcription and control 
mechanisms for cell differentiation. During early pancreatic development, 
differentiation of endocrine progenitor cells into hormone-producing islet cells is 
tightly regulated by the sequential expression of specific transcription factors.
1.5.1 MODY
Maturity-onset diabetes of the young (MODY) is a subtype of diabetes 
characterized by autosomal dominant inheritance, non-ketotic diabetes mellitus, 
an age of onset of less than 25 years and a major defect in pancreatic beta-cell 
function. In humans, mutations in specific genes lead to the various forms of 
MODY. Mutations in glucokinase (GK), the glucose sensing enzyme, lead to 
MODY2, with the remaining 5 types of MODY resulting from defects in genes 
encoding for transcription factors: HNF-4a (MODY1), HNF-1a (MODY3), Pdx-1 
(MODY4), HNF-ip (MODY5) and NeuroDI (MODY6) (61).
12
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1.5.2 Pdx-1
Pdx-1 (pancreatic duodenal homeobox-1), which is expressed in adult beta-cells, 
has been reported to regulate the transcription of the insulin gene (62), GLUT-2 
(63), GK (64) and Nkx 6.1 (65) (Fig. 1). It first appears in the digestive tract of the 
mouse at embryonic day (e) 8.5, a day before the dorsal bud of the pancreas 
develops. Pdx-1 is considered to be the master regulator of pancreatic 
development and beta-cell differentiation. It has a dual role as an inducer of the 
endocrine lineage from ductal epithelial cells and in the maturation of beta-cells 
(66). Pdx-1 may be directly activated by the transcription factors NeuroDI (67), 
Hnf-1a and Hnf-3p (68). Pancreatic agenesis occurs in Pdx-1 null mutant mice 
(16).
A characteristic feature of Pdx-1 is the highly conserved homeodomain, a 61 
amino acid domain that builds a helix-turn-helix motif with three a-helical 
segments, the third helix being the DNA-recognition helix (69). Other conserved 
sequences, which mediate transactivation, are found in the N-terminal (69). This 
transactivation domain is situated within the first 79 amino acids, with amino 
acids 32-38 and 60-73 being of crucial importance (70;71).
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Fig. 1 Regulation of pancreatic islet transcription factors and glucose 
sensing genes
Pdx-1 is the major transcription factor involved in early pancreatic development 
and maintenance of beta-cell function. The transcription factors, NeuroDI, Hnf- 
1a and Hnf-3p are proposed to activate Pdx-1 gene expression directly. Both 
Pdx-1 and NeuroDI can regulate the transcription of the insulin gene. Pdx-1, 
however, also activates Nkx 6.1 gene expression, a role it shares with Hnf-3p. In 
addition, the expression of the glucose transporter, GLUT-2, and the glycolytic 
enzyme, glucokinase, which are both involved in glucose sensing, has been 
reported to be regulated by Pdx-1. Regulation of the expression of specific 
transcription factors is especially important during pancreatic development as 
any mutational defects would lead to the development of the MODY subtypes of 
diabetes.
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Pdx-1 links glucose metabolism to the regulation of insulin gene transcription 
(72). Glucose activates Pdx-1 through an insulin-dependent cell signalling 
pathway involving phosphotidylinositol 3-kinase, and the stimulation of this 
pathway leads to phosphorylation and activation of a cytoplasmic form of Pdx-1 
that translocates to the nucleus (73). Thus lower levels of circulating glucose, in 
rats exposed to a low protein diet, could contribute to the reduced Pdx-1 
expression, and this indicates that a low protein diet during the foetal and 
lactation periods leads to alterations in islet size and functionality. These effects 
are linked to a reduction in Pdx-1 protein, but not Pdx-1 mRNA expression. The 
reintroduction of a normal diet, immediately after birth, normalizes the expression 
of Pdx-1 protein and restores islet cell mass and beta-cell secretory capacity 
(31).
A recent study showed that by inhibiting glucose-stimulated insulin secretion 
(GSIS) through the inactivation of insulin-like growth factor-1 receptor (IGF-1R), 
elevated glucose concentrations regulate preproinsulin, Pdx-1 and GK gene 
expression in beta-cells. These studies showed that released insulin, acting via 
insulin receptor (IR), is likely to be an important mediator of the effects of glucose 
on Pdx-1 gene expression in normal MIN6 beta-cells. However, insulin- 
independent mechanisms are sufficient to allow the control by glucose of GK 
gene expression in wild type cells and the regulation of the Pdx-1 gene in the 
absence of IGF-1R (74).
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Pdx-1 regulates the expression of GLUT-2 in a dosage dependent manner, 
suggesting that lowered Pdx-1 activity may contribute to the development of 
Type 2 diabetes by causing impaired expression of both GLUT-2 and insulin. 
Early loss of GLUT-2 expression is involved in the development of 
hyperglycaemia, in Pdx-1 beta-cell-specific mutants, and the combined loss of 
GLUT-2 together with the gradual decrease of insulin expression leads to the 
manifestation of diabetes. Thus lowered Pdx-1 expression, or activity resulting in 
impaired expression of both GLUT-2 and insulin, could cause hyperglycaemia 
which may progress to Type 2 diabetes. In mature beta-cells, Pdx-1 expression 
is required to maintain insulin production, GLUT-2 expression and glucose 
homeostasis (75).
Using HIT-T15 cells, a clonal beta-cell line, studies on the impact of glucose 
levels on Pdx-1 expression in pancreatic beta-cells suggest that while persistent 
hyperglycaemia (16 mmol/l glucose) extinguishes Pdx-1 mRNA and protein 
expression, hypoglycaemia (0.8 mmol/l glucose) actually restores Pdx-1 levels 
(76). Pdx-1 mRNA and protein expression were down-regulated in beta-cells 
from which Hnf-3(3 was deleted in a mouse mutant model (77). In addition, Hnf- 
3p was demonstrated to be an essential upstream factor that, directly or 
indirectly, regulates Pdx-1 levels in beta-cells in vivo (77).
16
Stellenbosch University http://scholar.sun.ac.za/
1.5.3 Pax 4
The paired domain homeobox gene, Pax 4, is expressed in the developing 
pancreas at e9.5. Homozygous Pax 4 deficient mice appear normal at birth but 
are growth retarded by 48h and die 3-5 days after birth (18). They lack beta- and 
delta-cells, but have an increase in alpha-cells. Pax 4 is essential for proper beta­
cell development and especially for their maturation and maintenance.
Pax 4 has been identified as a regulator of endocrine development (18). Indirect 
evidence from mice, containing the p-galactosidase coding sequence inserted 
into the Pax 4 gene, suggests that Pax 4 expression is restricted to the beta-cells 
at birth (18). Insulin expressing cells are detected, at e10.5, in the null mutants 
for Pax 4, suggesting that insulin transcription can occur in the absence of Pax 4. 
Pax 6, which is highly related to Pax 4, is also required for normal endocrine 
pancreatic development (78), and double null mutants for both Pax 4 and Pax 6 
fail to produce any mature pancreatic endocrine cells (78), suggesting that these 
two factors together are required for endocrine cell differentiation. Using RT- 
PCR, Pax 4 expression was shown to peak early, at e13.5, in pancreatic 
development of the foetal mouse but is undetectable in adult islets (79). It 
appears that Pax 4 can function as a transcriptional repressor and its expression 
early in pancreatic development may allow it to suppress alpha-cell differentiation 
and permit beta-cell differentiation (79). Using a rat glucagon-producing cell line, 
Pax 4 was shown to act as a repressor of glucagon gene expression and was 
shown to inhibit the insulin promoter in the absence of Pax 6, suggesting an
17
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active repression mechanism of Pax 4 (80). Another study showed that Pax 4 
binds, with high affinity, to Pax 6 target sites of the glucagon gene promoter 
suggesting a competition mechanism of transcriptional inhibition (81). Pax 4 has 
been shown to be unable to inhibit Hnf-3a transcription, but was able to inhibit 
transcription of the glucagon gene, by DNA competition with Pax 6 (81). Indeed, 
the repression, by Pax 4 of Pax 6-mediated transcription could play a role in the 
restriction of glucagon gene expression to alpha-cells during pancreas 
development (81).
1.5.4 NeuroDI
NeuroDI (neurogenic differentiation 1 or BETA2) is a cell-type restricted basic 
helix-loop-helix transcription factor expressed in all endocrine cells (82). It is 
expressed in the mouse pancreatic bud at e9.5. Homozygous null mutations of 
the NeuroDI gene show a marked reduction in beta-, alpha- and delta-cells in 
newborn mice (17).
1.5.5 Hnf-1a
The hepatocyte nuclear factor, Hnf-1a, is expressed at e13.5 in the developing 
mouse pancreas and in beta-cells during adulthood. This transcription factor has 
been proposed to regulate the genetic expression of insulin and the glucose 
transporter, GLUT-2 (83;84). It also appears to be essential for maintaining 
insulin storage (83). Defects in the Hnf-1a gene, in mice, result in the
18
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development of Type 2 diabetes two weeks after birth. Null mutant mice for Hnf- 
1a have impaired GSIS (85).
1.5.6 Hnf-3p
Hnf-3p (Foxa2) first appears in the early endodermal layer, from which the 
pancreas arises, and is later expressed in all of the islet cell types (86;87). This 
winged helix transcription factor is required to maintain proper circulating levels 
of insulin and glucagon for glucose homeostasis (88). Hnf-3p is believed to 
regulate transcription of the Nkx 6.1 gene (65).
1.5.7 Nkx 2.2
The Nk homeobox gene, Nkx 2.2, appears at e9.5 in the whole pancreatic bud 
and is expressed in all but delta islet cells (89). It may be required for terminal 
differentiation of beta-cells or for expression of the insulin gene (89). It is also 
required for maintenance of Nkx 6.1 expression. Nkx 2.2 mutant mice become 
diabetic after birth and die due to hyperglycaemia.
1.5.8 Nkx 6.1
Nkx 6.1 is restricted to differentiated beta-cells (90) and appears to be specific for 
foetal cell differentiation and function (90-92). It is expressed at e10.5 in the 
pancreatic bud. Targeted disruption of the Nkx 6.1 gene, in mice, results in 
inhibition of beta-cell formation (90) as it is required for expansion and terminal 
differentiation of beta-cell progenitors.
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1.6 The beta-cell glucose sensing genes
1.6.1 GLUT-2
The glucose transporter, GLUT-2, together with the glycolytic enzyme, 
glucokinase (GK), plays a major role in GSIS (Fig. 2). Glucose is transported into 
cells by facilitated diffusion, which involves binding of glucose to glucose 
transport proteins (93). GLUT-2 is a high-Km facilitative glucose transporter that is 
expressed by beta-cells in normal animals (93). In the foetal rat pancreas, which 
begins to develop around e9, the duct cells transiently express GLUT-2 which is 
normally only expressed in mature beta-cells (94). After e16, GLUT-2 disappears 
from the ductal cells and appears in the newly formed beta-cells (24). In the rat, 
cells co-expressing GLUT-2 and insulin, at e17, form beta-cells (95).
GLUT-2 is expressed in numerous foetal and adult tissues including pancreas, 
liver, intestine, brain and kidney (93;96) and is most abundant in the liver, kidney 
and small intestines in declining order (97). GLUT-2 was shown to be localized in 
rat pancreatic islets, primarily to the microvesicular patterns of beta-cell 
membranes adjacent to neighbouring endocrine cells (98) and in the endodermal 
epithelial cells of the entire pancreatic primordium (94;98).
20
Stellenbosch University http://scholar.sun.ac.za/
Fig. 2 A brief overview of glucose-stimulated insulin secretion
GSIS is initiated when elevated glucose levels are sensed by GLUT-2 and 
transported into the beta-cell. Glucose is then phosphorylated into glucose-6- 
phospate by GK thereby initiating glycolysis. An increase in the ATP:ADP ratio 
results in closure of the K+ATp-channels. Ca2+ enters the beta-cell via the voltage- 
gated Ca2+-channels. The resultant increase in intracellular Ca2+ concentration 
triggers insulin exocytosis. In rodent models of Type 2 diabetes, GLUT-2 
expression is reduced.
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In normal human islets, insulin cells are strongly positive for GLUT-2, especially 
adjacent to the cell membranes (99). Recent studies report the expression of 
GLUT-2 mRNA and protein to be significantly lower in foetal and suckling rat 
pancreatic islets than in adult rat islets (100). Furthermore, in foetal islets, GLUT- 
2 mRNA and protein increased as a function of increasing glucose concentration 
(100). After being fed a high energy diet (2.93 Kcal/g), hyperglycaemic and 
hyperinsulinaemic rats (Psammomys obesus) showed a decrease of 71% (after 1 
week) and 94% (after 3 weeks) in GLUT-2 immunostaining on the beta-cell 
membrane (101).
In the adult rat pancreas, GLUT-2 expression has only been described in beta- 
cells, where it may be essential for their glucose sensing function (96). The loss 
of responsive beta-cells to glucose is associated with a decrease in glucose 
uptake by islets and a profound reduction in immunodetectable GLUT-2 and 
GLUT-2 mRNA (102). Impaired expression of GLUT-2 may impair glucose 
sensing and result in hyperglycaemia (103). A reduction of GLUT-2 develops in 
concert with the onset of steady state hyperglycaemia.
Situations of increased insulin demand include a HFD, ageing and pregnancy 
(104). A HFD has been shown to decrease GLUT-2 and GK expression in the 
pancreata of adult rats fed a HFD for 10 weeks (34). More recently, mice fed a 
HFD for 8 weeks showed impaired glucose tolerance accompanied by 
compromised translocation of GLUT-2 to the plasma membrane and of Pdx-1 to
22
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the nucleus (105). Plasma insulin concentrations were lower in rats fed a HFD 
and the glucose levels were higher when compared to those on a high 
carbohydrate diet (34). Evidence suggests, therefore, that a HFD could impair 
beta-cell trafficking of factors important for both beta-cell glucose recognition and 
insulin gene expression.
1.6.2 Glucokinase
The high-K™ glucose phosphorylating enzyme, GK, is expressed in islets where it 
regulates pancreatic glucose sensing (106). In the mature beta-cell, GK regulates 
glucose homeostasis by catalyzing the conversion of glucose to glucose-6- 
phosphate, after glucose is transported into the beta-cell by GLUT-2. GK appears 
in both beta- and alpha-cells of foetal rat islets at e16, but is predominantly 
expressed by beta-cells (107). The GK content of foetal islets was found to be 
significantly higher than that of suckling and adult rats (100).
The unique kinetics of GK underlie the ability of these cells to sense and respond 
to fluctuations in plasma glucose concentration (108). Modelling of changes in 
GK activity, as well as studies of the effects of graded increases in the enzyme, 
have established that glucose phosphorylation is the key point of control for 
glycolytic flux in the beta-cell (109; 110). Consequently, even small changes in 
GK activity can be physiologically significant since they directly affect the 
threshold for GSIS (108). Overexpression of GK reduces the blood glucose 
concentration and appears to prevent the development of Type 2 diabetes (108).
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Male GK locus transgenic mice that were fed a HFD were protected against the 
development of hyperinsulinaemia and hyperglycaemia, even though these 
animals were as obese as their non-transgenic littermates (111). This suggests 
that exploring ways to enhance GK activity could result in an effective strategy for 
treating diabetes.
Insulin secretion depends upon glucose metabolism and GK exerts nearly total 
control on the rate of glycolysis in beta-cells (112). Insulin is able to stimulate GK 
translocation and activation in the absence of glucose (113), while inhibition of 
insulin secretion or insulin receptor function has been found to block glucose- 
stimulated GK translocation and conformational changes (113). Together these 
results point to the regulation of GK localization and activity by insulin secreted 
by beta-cells in response to glucose (113). The enzymatic activity of granule- 
bound GK alone can support GSIS from the beta-cell (113). This is based on the 
observation that under glucose-starved conditions, the measured GK activity is at 
least 50% of the total activity measured under high glucose conditions. Under 
these low glucose conditions, virtually all of the endogenous GK was found to be 
associated with granules (113). These observations highlight the fact that GK 
activity in the beta-cells is modulated over a narrow range (113). Changes in the 
GK conformation and activation state, that correlate with GK association and 
dissociation from the granule, provide a novel mechanism for rapidly altering the 
rate of insulin secretion in response to changes in glucose concentration (113).
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1.7 Insulin
Insulin first appears in the developing mouse pancreas at e12 (12). When foetal 
rat pancreatic cells were isolated from the pancreatic primordium, on e12-14 of 
pregnancy, and cultured for 48h in the presence of 5 mmol/l glucose, the cultured 
cells from e12 foetuses secreted 1 fmol insulin per pancreas in response to 5 or 
15 mmol/l glucose (114). Insulin release from cells at e14 was 75 amol/min per 
pancreas when the cells were perifused for 15-20 min in 5 mmol/l glucose within 
3h of isolation (114). The insulin content of rat pancreata from e13 was 0.06 pmol 
per pancreas and increased approximately 20-fold every second day up to 6.7 
pmol on e17. Between e17 and e19 the pancreatic insulin content increased 
about 5-fold to 39 pmol (114). The data suggest that critical components of the 
insulin-secretory machinery, including KATp-channels and GK, are present in the 
beta-cell earlier than previously anticipated (114). The study showed that rat 
beta-cells, from the early foetal period, respond to an increase in glucose 
concentration with the release of insulin, although to a much smaller extent than 
adult cells (114).
The synthesis of preproinsulin from insulin mRNA occurs through the rough 
endoplasmic reticulum and is followed by proteolytic cleavage at the Golgi 
apparatus, generating mature insulin and C-peptide. Insulin and C-peptide are 
stored, in secretory granules, ready for release following physiological 
stimulation. Glucose is the main stimulus for insulin release. During prolonged 
fasting, however, FFA provide the body with an alternative fuel to glucose,
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thereby reserving glucose for the brain and conserving body proteins that would 
usually be utilized as gluconeogenic substrates.
The islet beta-cell is specifically adapted for:
(i) synthesis of the insulin precursor, preproinsulin,
(ii) its processing by proteolytic cleavage to produce insulin,
(iii) storage of large quantities of insulin in membrane-limited vesicles,
(iv) secretion of insulin in response to specific stimuli such as glucose 
(115).
Insulin regulates numerous diverse metabolic processes through binding to a 
high-affinity cell-surface glycoprotein receptor. Elevated insulin levels result in 
down-regulation of the insulin receptor (IR) by decreasing their numbers at the 
cell surface. This is brought about by increased internalization and degradation 
and also by decreasing the IR’s tyrosine kinase activity (115). The major targets 
of insulin, and therefore sites of glucose uptake, are liver, skeletal muscle and 
adipose tissue. Upon ligand binding, the IR phosphorylates the insulin receptor 
substrates IRS1 and IRS2, coupling IR to its downstream effector molecules, 
ultimately leading to intracellular changes in cell behaviour and gene expression 
(116).
Targeted disruption of the IR gene selectively in beta-cells results in impaired 
glucose tolerance in mice (117). However, disruption of the insulin-like growth
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factor-1 receptor (IGF-1R) gene leads to a more complex phenotype, 
characterised by resting hyperglycaemia and abnormal glucose tolerance, but no 
significant changes in preproinsulin gene expression or islet insulin content (118). 
Although these mice show normal beta-cell growth and development, GSIS is 
inhibited in vivo and in vitro and the expression of GLUT-2 and GK are reduced 
(118;119).
The resultant secretion of insulin from beta-cells is multiphasic, comprising two 
primary phases (120), the first being transient, rapid and lasting for 2-5 minutes. 
In the second progressively increasing phase, glucose continually amplifies its 
own signal throughout the duration of the stimulus. Other nutrients, such as 
amino acids (121) and FFA (122), can also stimulate insulin release. FFA can 
potentiate GSIS by activating protein kinase C by a mechanism that appears to 
be mediated by Ca2+ mobilization (123).
Upon release from the beta-cell, the principal metabolic function of insulin is to 
increase the rate of glucose transport into muscle and adipose tissue. 
Additionally, insulin enables transmembrane transport of amino acids, glycogen 
formation, glucose conversion to triglycerides, nucleic acid synthesis and protein 
synthesis (124). It also inhibits endogenous glucose production by the liver and 
kidney (125).
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Impaired beta-cell function is characterized by an absent first-phase response to 
an intravenous glucose load and a markedly reduced second-phase response 
(126). It is well established that the effects of exogenous FFA on insulin secretion 
are time-dependent both in vivo and in vitro (127). Short-term exposure to FFA 
stimulates insulin secretion (122), whereas long-term exposure to FFA decreases 
insulin secretion (53;128). Prolonged elevations in FFA, as in obesity, have been 
shown to induce secretory defects by selectively desensitizing the beta-cell 
response to glucose (52; 128). Chronically elevated FFA are detrimental to beta­
cell function, resulting in reduced insulin secretion.
In rats, 24h exposure to FFA transiently increased insulin mRNA levels at basal 
(5.6 mmol/l) levels of glucose (129). In contrast, 24h exposure of rat islets to 
palmitate decreased preproinsulin mRNA levels in the presence of a high 
glucose level (130). Thus it appeared that FFA inhibit insulin gene expression 
only in the presence of elevated glucose levels. This was confirmed in a study 
using isolated rat islets where palmitate was shown to decrease the expression 
of the insulin gene in the presence of 16.7 mmol/l glucose, partly through 
inhibition of insulin gene promoter activity (131). In support of this, another study 
showed that 48h exposure to palmitate decreases insulin gene expression in the 
presence of 30 mmol/l glucose via negative regulation of Pdx-1 (132). Recently, 
evidence was provided for the involvement of the fatty acid esterification pathway 
in mediating the inhibition of insulin gene expression by prolonged FFA exposure 
(133). Neutral lipid mass was increased in isolated rat islets following a 72h
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exposure to palmitate, in the presence of 16.7 mmol/l glucose, that was inversely 
correlated to insulin mRNA levels. Depletion of insulin content may be a 
contributory factor to FFA-induced beta-cell dysfunction.
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1.8 Hypothesis
The exposure of pups to a maternal high fat diet during gestation and/or lactation 
will result in a decrease in the expression of:
(i) Pdx-1 and Pax 4, important regulatory transcription factors involved in 
pancreatic and beta-cell development,
(ii) GLUT-2, the beta-cell specific glucose transporter, and
(iii) Glucokinase, the pancreatic glucose sensing enzyme required for 
glycolysis within the beta-cell,
which will adversely affect beta-cell development and function.
1.9 Aims of the study
To investigate, in the neonatal and weanling rat, the effect of exposure to a 
maternal high fat diet during gestation and/or lactation on:
(i) body weight
(ii) circulating glucose concentrations
(iii) circulating insulin concentrations
(iv) beta-cell development
(v) alpha-cell development
(vi) expression of the pancreatic transcription factors, Pdx-1 and Pax 4
(vii) expression of the beta-cell specific glucose sensing genes, GLUT-2
and glucokinase
30
Stellenbosch University http://scholar.sun.ac.za/
CHAPTER 2 
MATERIALS AND 
METHODS
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Study design 
2.1.1 Experimental groups
All animal experiments were approved by the Ethics Committee of the Medical 
Research Council (MRC), South Africa, rigorously adhering to the ethical NIH 
guidelines for the care and use of laboratory animals. Wistar rats were housed 
individually with free access to food and water at the MRC Primate Unit (Cape 
Town, South Africa). The room was maintained at a temperature of 24°C with a 
12h light cycle.
The experimental groups are summarized in Table 1. Pregnant rats were fed a 
HFD for the first (Group 1 dams), second (Group 2) or third (Group 3) week, or 
for all three (Group 4) weeks of gestation. After birth, the neonatal pancreata 
were collected from Groups 1-5. The individual neonatal groups were therefore 
exposed to a maternal HFD during the either the first (Group 1 neonates), 
second (Group 2) or third (Group 3) week, or all three (Group 4) weeks of 
gestation.
For the weanling Groups 6-10, the same range of diets were used in utero, as for 
Groups 1-5 and the dams were fed a standard laboratory diet during lactation. 
Additional weanling Groups 11-14 comprised dams fed a HFD throughout 
gestation and for specific periods of weaning, with one experimental group 
(Group 15) exposed to a standard laboratory diet for gestation and a HFD during 
lactation. The control groups comprised dams (Group 5 dams) maintained on a
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standard laboratory diet and their offspring (Group 5 neonates and Group 10 
weanlings).
2.1.2 Composition of diets
The standard laboratory diet comprised 10% fat, 15% protein and 75% 
carbohydrate as energy (2.6 kcal/g) while the HFD contained 40% fat, 14% 
protein and 46% carbohydrate (2.06 kcal/g).
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The period of gestation in the Wistar rat is 3 weeks and lactation also lasts for 3 
weeks. The weeks of gestation and/or lactation during which the dams were 
maintained on a HFD represent the periods of exposure of their offspring to a 
HFD. The experimental groups depicted in the table represent neonates (Groups 
1-4) and weanlings (Groups 6-9, 11-15) that were exposed to a maternal HFD for 
specific periods of gestation and/or lactation. The control groups are Group 5 for 
the neonates and Group 10 for the weanlings. These offspring were only 
exposed to a standard laboratory (control) diet. When not exposed to a HFD, for 
example, weeks 2 and 3 of Group 1, the pups were exposed to a standard 
laboratory diet. Group 1 and Group 6 had identical exposure to a maternal HFD 
in utero, i.e. for the first week of gestation, with neonates from Group 1 
terminated at birth and weanlings from Group 6 terminated at 3 weeks of age. 
This is the same for Groups 2-4 and Groups 7-9, respectively. The weanling 
Groups 11-14 were exposed to a maternal HFD throughout gestation and for 
specific weeks of lactation. Group 15 weanlings were only exposed to a maternal 
HFD throughout lactation.
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Tablel Experimental groups
Group Period of exposure to a maternal 
HFD or standard laboratory 
(control) diet during gestation
Period of exposure to a maternal 
HFD or standard laboratory 
(control) during weaning
1 HFD: First week
Control: Second and third week
Rats terminated at birth
2 HFD: Second week 
Control: First and third week
Rats terminated at birth
3 HFD: Third week
Control: First and second week
Rats terminated at birth
4 HFD throughout gestation Rats terminated at birth
5 Control diet throughout gestation Rats terminated at birth
6 HFD: First week Control diet throughout weaning
7 HFD: Second week Control diet throughout weaning
8 HFD: Third week Control diet throughout weaning
9 HFD: Throughout Control diet throughout weaning
10 Control diet throughout gestation Control diet throughout weaning
11 HFD: Throughout HFD: First week
12 HFD: Throughout HFD: Second week
13 HFD: Throughout HFD: Third week
14 HFD: Throughout HFD: Throughout
15 Control diet throughout gestation HFD: Throughout
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Determination of circulating glucose and insulin concentrations 
2.2.1 Mothers
Maternal food intake, body weight and circulating glucose and insulin 
concentrations were monitored during pregnancy. Blood, for measurement of the 
baseline circulating glucose and insulin levels, was collected from the tail veins of 
female virgin Wistar rats (n = 8 per group) fasted for 3h. Pregnancy was 
determined by the presence of a vaginal plug(s). At gestational days 7 and 14, 
and after delivery, dams were fasted for 3h and blood collected from the tail vein. 
For this procedure, dams were anaesthetized using an anaesthetic machine 
(Motivus Resuscitator Type AV, Crest Healthcare Technology Ltd, 
Johannesburg, South Africa) with fluothane (Halothane, AstraZeneca 
Pharmaceuticals, Johannesburg, South Africa) and 2% oxygen. Once 
anaesthetized, the tip of the tail was heated with a UV lamp, to facilitate blood 
flow, then snipped with a surgical blade and blood glucose concentrations 
determined using a glucometer (Precision QID, MediSense Inc., Oxfordshire, 
UK). Blood was collected in tubes and placed on ice before centrifugation 
(Biofuge 13, Heraeus Sepatech, Osterode am Harz, Germany) at 13 000 rpm for 
10 min at RT and the serum used to determine the insulin concentrations with a 
Rat Insulin RIA Kit (Linco Research Inc., Missouri, USA).
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2.2.2 Neonates and weanlings
The body weights, circulating glucose (Glucometer) and insulin (Rat Insulin RIA 
kit) levels in the neonates (n = 6 per group) and weanlings (n = 6 per group) were 
measured at postnatal days 1 and 21 respectively.
Molecular biology 
2.3 RNA isolation
RNA was isolated from one-day-old neonatal (n = 10 per group) and 3-week-old 
weanling (n = 10 per group) pancreata using an RNeasy Mini Kit (Qiagen GmbH, 
Hilden, Germany). The tissues were placed in 2 ml cryotubes (Greiner Bio-One 
GmbH, Frickenhausen, Germany) and crushed (in the tubes) in liquid nitrogen. A 
volume of 600 pi RLT lysis buffer was added and the tissue was further disrupted 
and homogenized using a sterile RNase-free 1 ml syringe (Jung-Rim, Seoul, 
South Korea). The lysate was passed through the syringe at least 5 times to 
ensure complete homogenization and to increase the RNA yields. The tissue 
lysate was transferred to a 2 ml tube (Eppendorf AG, Hamburg, Germany) and 
centrifuged for 3 min at maximum speed in a microcentrifuge (Eppendorf Model 
5414, Hamburg, Germany). The supernatant was carefully transferred to another 
2 ml tube (Eppendorf), by pipetting, and the lysate (supernatant) used in the 
subsequent steps. One volume (600 pi) of 70% ethanol (Merck KGaA, 
Darmstadt, Germany) was added to the cleared lysate and mixed by pipetting. 
The sample (to a maximum of 700 pi), including any precipitate that may have 
formed, was applied to an RNeasy Mini column placed in a 2 ml collection tube
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(Qiagen). The tube was gently closed and centrifuged for 15 s at maximum 
speed (^10 000 rpm) and the flow through discarded. If the volume exceeded 
700 pi, the remaining aliquots were loaded successively into the RNeasy column 
and centrifuged as above, discarding the flow through after each centrifugation 
step. A volume of 700 pi RW1 buffer was added to the RNeasy column placed in 
the same collection tube. The tube was gently closed and centrifuged for 15 s at 
maximum speed to wash the column. The flow through and collection tube were 
then discarded. The RNeasy column was transferred into a new 2 ml collection 
tube (Qiagen) and 500 pi of RPE (the buffer system allows up to 100 pg of RNA 
longer than 200 bases to bind to the RNeasy silica-gel membrane) was pipetted 
onto it. The tube was gently closed and centrifuged for 15 s at maximum speed 
to wash the column. The flow through was discarded and another 500 pi of RPE 
buffer was added onto the column, reusing the same collection tube. The sample 
was centrifuged for 2 min at maximum speed to dry the RNeasy silica-gel 
membrane to prevent residual ethanol from interfering with downstream 
reactions. This centrifugation ensured that no ethanol was carried over during 
elution. Following centrifugation, the RNeasy column was removed carefully from 
the collection tube to avoid contact with the flow through, which would result in 
ethanol being carried over. The RNeasy column was finally transferred to a new
1.5 ml tube (Qiagen) and 30 pi of RNase-free water was pipetted directly onto the 
RNeasy silica-gel membrane. The samples were then centrifuged for 1 min at 
maximum speed to elute the purified RNA.
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A First Strand cDNA synthesis kit for RT-PCR (Avian Myeloblastosis Virus 
(AMV); Roche Diagnostics GmgH, Penzberg, Germany) was used for the first 
strand synthesis of single-stranded cDNA from each RNA sample for use as a 
template for PCR. All vessels and pipette tips that were used for cDNA synthesis 
were autoclaved to eliminate the risk of RNase contamination. The reagents 
were thawed on ice and briefly vortexed before starting. Because of the small 
reaction volume of the reagents required for each first strand cDNA synthesis 
reaction, a larger amount of master mix was prepared (Table 2), centrifuged 
briefly, and aliquoted into reaction tubes before adding the RNA samples. The 
preparation of the master mix eliminated the need to repeatedly pipette small 
volumes, thus yielding greater consistency between samples.
2.4 First strand cDNA synthesis
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Table 2 Preparation of Master Mix for cDNA synthesis
Reagent Volume/10 pi 
1 sample
Volume/250 Ml 
25 samples
Final Concentration
10X Reaction Buffer 1 pi 25 pi 1X
25mM IVIgCb 2 Ml 50 Ml 5mM
dNTP mix 1 Ml 25 Ml 1mM
Primer:
Oligo-p(dT)i5 primer or 
Random primer p(dN)6
1 Ml 25 Ml 0.04 A26o units (1.6 Mg) 
or 0.08 A26o units (3.2 Mg) 
respectively
RNase inhibitor 0.5 Ml 12.5 Ml 50 units
AMV reverse 
transcriptase
0.4 Ml 10 Ml >20 units
RNA sample* 2-4 Mlt 25-50 Mlt -
*RNA samples were omitted during preparation of the master mix and added 
individually after the master mix was aliquoted into separate tubes.
|A  volume of either 2 pi or 4 pi of RNA was added to the mixture, depending on 
the concentration of the RNA samples. For groups 1-10, 4 |jl of RNA was added 
to 5.9 pi of the master mix. For groups 11-15 only 2 |jl of RNA and an additional 
2 pi of sterile water (Sabax, Ladmed, Durban, South Africa) was added to 5.9 jjl 
of the master mix as these samples had a higher RNA concentration (estimated 
at 10X higher).
A volume of 1 pi of control neo RNA was used as a positive control (adding 3.1 pi 
of sterile water to the master mix).
A volume of 1 |jl of sterile water was added, instead of RNA, as the negative 
control.
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After preparation, the mixture was briefly vortexed and centrifuged to collect the 
sample at the bottom of the microfuge tube. The reaction was incubated at 25°C 
for 10 min, then at 42°C for 60 min. During the first incubation, the primer 
anneals to the RNA template. The RNA is subsequently reverse transcribed, 
resulting in cDNA synthesis during the second incubation. Following the 42°C 
incubation, the AMV reverse transcriptase, which synthesizes the new cDNA at 
the sites determined by the primer used, was denatured by incubating the 
reaction of 99°C for 5 min and then cooled to 4°C for 5 min. The cDNA was then 
used for RT-PCR experiments.
2.5 RT-PCR
The cDNA synthesized from RNA isolated from Groups 1-15 was then used in 
the subsequent RT-PCR experiments (Table 3a). All the cDNA was diluted 1:10 
with sterile water before use for RT-PCR. All the primer sets (forward and 
reverse) for each of the target genes, viz. Pdx-1, Pax 4, GLUT-2 and GK, were 
diluted in sterile water to give a concentration of 100 pM/pl. Each primer was 
then further diluted as follows: 10 pi of 100 pM/pl primer added to 90 pi of sterile 
water to give a 10 pM/pl working dilution to be used for RT-PCR. A master mix 
was prepared for RT-PCR (Table 3b).
2.5.1 Primer design
The PCR products visualized on the agarose gel were 169 bp for Pdx-1, 132 bp 
for Pax 4, 100 bp for GLUT-2 and 148 bp for GK.
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Primers were designed using the Primer3 website and were produced and 
purified by PAGE/HPLC (IDT, Coralville, IA, USA). The primer sequences were 
as follows:
Pdx-1 forward: 5’- GCT GGA GCT GGA GAA GGA AT -3’
Pdx-1 reverse: 5’- CGT TGT CCC GCT ACT ACG TT -3’
Pax 4 forward: 5’- CTC GAA TTG CCC AGC TAA AG -3’
Pax 4 reverse: 5’- CCC GAA GGA CTC GAT TGA TA -3’
GLUT-2 forward: 5’- CAG TGG AGC GTG AAG ACA AA -3’
GLUT-2 reverse: 5’- AGG GAA GGA GAA GGT GAA GC -3’
GK forward: 5’- CAG TGG AGC GTG AAG ACA AA -3’
GK reverse: 5 - AGG GAA GGA GAA GGT GAA GC -3’
Porphobilinogen deaminase (PBGD), the housekeeping gene used for the PCR 
experiments, was purified by standard desalting:
PBGD forward: 5’- GCA TAC AGA CCG ACA CTG TGG -3’
PBGD reverse: 5’- CTC TGG CAA GGT TTC CAG GG -3’
2.5.2 RT PCR programme
RT-PCR was done using the PCR Sprint (Table 3a; Thermo Hybaid, Milford, MA, 
USA). Briefly, the cDNA sample was denatured at 94°C for 1 min for 1 cycle. In 
the next stage, the sample was denatured at 94°C for 30 s, annealed at 52°C (for 
Pdx-1, Pax 4), 57°C and 55°C (GLUT-2) or 57°C (GK), then elongated at 72°C for
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1 min. This stage was repeated for 30 cycles. The final stage was an elongation 
step at 72°C for 5 min comprising 1 cycle.
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Table 3a RT-PCR programme
Temperature Time PCR step
Stage 1 Step 1
94UC 1 min Denaturation (1 cycle)
Stage 2 Step 1
94UC 30 s Denaturation
52, 55 or 57UC 30 s Annealing
72UC 1 min Elongation (30 cycles)
72UC 5 min Final elongation (1 cycle)
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Table 3b Preparation of master mix for RT-PCR
Reagent Volume/10 pi 
reaction
Volume/50 pi 
reaction
Final
Concentration
10X Reaction 
Buffer
1 pi 5 pi 1X
Taq Polymerase 0.08 pi 0.4 pi 0.4 U
dNTP (10 mM) 0.2 pi 1 pi 200 mM
BSA (20 mg/ml) 0.125 pi 0.625 pi 50 pg/ml
Primer Forward* 0.5 pi 2.5 pi 5 pM
Primer Reverse* 0.5 pi 2.5 pi 5 pM
Water 6.265 pi 31.325 pi -
Total 10 pi 50 pi -
*A volume of 0.5 pi (concentration of 5 pM) was added to the master mixes for 
Pdx-1, Pax 4 and GK. For GLUT-2, 1 pi of primer was added (concentration 10 
pM). The RT-PCR had to be further optimized for GLUT-2 and GK where 0.4 pi 
MgCb was added per 10 pi reaction to give a final MgCl2 concentration of 2.5 
mM as opposed to the 1.5 mM concentration of the Pdx-1 and Pax 4 mixes.
A volume of 9 pi master mix was added to 1 pi cDNA sample for each reaction.
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2.5.3 Annealing temperatures for primer pairs
An annealing temperature of 52°C was used for RT-PCR for both Pdx-1 and Pax 
4. The primers for these transcription factors were used under standard PCR 
conditions without changing any parameters. For GLUT-2, the concentration of 
the primer pair was increased to 10 pM, i.e. 1 pi of each primer was added per 10 
pi reaction. A touchdown PCR was done where the annealing temperature was 
57°C for the first 10 cycles followed by 55°C for the remaining 20 cycles. In 
addition, a MgCI2 titration was done by increasing the 1.5mM MgCI2 
concentration present in the PCR mix to 2, 2.5 and 3 mM (Table 4). A 2.5 mM 
MgCI2 concentration was optimum for the PCR. For GK the primer pair worked 
best at an annealing temperature of 57°C. The MgCI2 concentration also had to 
be increased to 2.5 mM (similar to GLUT-2). Primers for the housekeeping gene, 
PBGD, worked well at annealing temperatures of 52, 55, and 57°C without 
changing any parameters under standard PCR conditions.
Optimization of RT-PCR
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Table 4 Preparation of mixes for MgCh titrations for GLUT-2 optimization
RT-PCR per 10 pi reaction
Reagent 1.5 mM 
MgCI2
concentration
2 mM MgCI2 
concentration
2.5 mM MgCI2 
concentration
3 mM MgCI2 
concentration
10X Reaction 
Buffer
1 pi 1 Ml 1 Ml 1 Ml
Taq
Polymerase
0.08 Ml 0.08 Ml 0.08 Ml 0.08 Ml
dNTP (10 mM) 0.2 Ml 0.2 Ml 0.2 Ml 0.2 Ml
BSA (20 
mg/ml)
0.125 Ml 0.125 Ml 0.125 Ml 0.125 Ml
Primer
Forward*
1 Ml 1 Ml 1 Ml 1 Ml
Primer
Reverse*
1 Ml 1 Ml 1 Ml 1 Ml
Water 5.265 Ml 4.765 Ml 4.265 3.765
MgCI2 0 0.5 1 1.5
Total 10 Ml 10 Ml 10 Ml 10 Ml
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2.5.4 Gel electrophoresis
The PCR products for each primer pair were visualized on a 1% agarose gel 
(Whitehead Scientific, Cape Town, South Africa). The 1% agarose gel was 
prepared as follows:
1 g of agarose (Molecular grade agarose D1-LE, Whitehead Scientific, Cape 
Town, South Africa),
2 ml of 50X TAE (tris-acetate) buffer
[242g of Tris was dissolved in 500 ml of water. 100 ml of 0.5 M Na2 EDTA, pH 8 
and 57.1 ml glacial acetic acid was added. The volume was adjusted to 11 with 
dH20 , and the solution was stored at RT], made up to 100 ml in dH20.
The mixture was boiled for 2 min until the agarose was dissolved. Then 10 pi of 
EtBr was added. The beaker containing the solution was swirled under running 
tap water to cool down. The agarose was then poured into a gel holder and 
allowed to set. After reaching a gel state, the agarose was transferred to a holder 
containing 1X TAE buffer and electophoresed at 100 V for 60 min using a Biorad 
Power Pac. The DNA fragments were visualized under UV light.
2.6 LightCycler PCR
Sybr green (nucleic acid gel stain) (Stratagene, Amsterdam, The Netherlands) 
was used: 1 j.il Sybr green with 99 p.l sterile water. Then 1 fil of 1:100 Sybr green 
was diluted with 99 |il water to give a 1:10 000 Sybr green working stock solution. 
A volume of 0.33 fil of this working solution was used per 10 ^l LightCycler PCR 
mix.
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Master mixes of the 600 |J volume were prepared for Pdx-1 (Table 5), Pax 4 
(Table 5), GLUT-2 (Table 6) and GK (Table 7). A volume of 1 cDNA of each 
sample was added individually to a capillary, followed by the addition of 9 fil of 
the respective master mixes. PBGD was prepared similarly to Pdx-1 and Pax 4, 
without any optimization, and worked well at the various annealing temperatures 
used for the different primer pairs.
2.6.1 Preparation of samples for LightCycler PCR
Capillaries were carefully placed in a LightCycler Centrifuge Adapter (Roche 
Diagnostics, Mannheim, Germany). A volume of 1 (al of each cDNA sample was 
added to a capillary, followed by 9 jiil of master mix. Caps were placed and 
tightened on the capillaries. The mixture was then centrifuged (Eppendorf 
centrifuge 5414) briefly for about 1 s. The capillaries were then carefully placed in 
the LightCycler PCR machine, and the appropriate programme was run for each 
primer. LightCycler PCR was completed after 30 cycles in 40-45 min.
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Table 5 Preparation of LightCycler master mixes for Pdx-1 and Pax 4 at an
annealing temperature of 52°C
Reagent Volume/10|nl reaction Volume/600|.il reaction
10X Reaction buffer 1 |il 60 ul
Taq Polymerase 0.08 nl 4.8 [i\
dNTP (10mM) 0.2 nl 12 ul
BSA (20 mg/ml) 0.125 nl 7.5 ul
Primer Forward 0.5 nl 30 ul
Primer Reverse 0.5 ul 30 ul
Sybr Green (1:10 000) 0.33 ul 19.8 ul
cDNA 1 nl 60 ul
Water 6.265 ul 375.9 ul
Total 10 ul 600 ul
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Table 6 Preparation of LightCycler master mix for GLUT-2 at annealing 
temperatures of 57°C and 55°C
Reagent Volume/10|ul reaction Volume/600pl reaction
10X Reaction buffer 1 pi 60 pi
Taq Polymerase 0.08 pi 4.8 pi
dNTP (10mM) 0.2 pi 12 pi
BSA (20 mg/ml) 0.125 pi 7.5 pi
Primer Forward 1pl 60 pi
Primer Reverse 1 pi 60 pi
Sybr Green (1:10 000) 0.33 pi 19.8 pi
MgCI2 0.4 pi 24 pi
cDNA 1 Pi 60 pi
Water 4.865 pi 291.9 pi
Total 10 pi 600 pi
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Table 7 Preparation of LightCycler master mix for GK at annealing
temperature of 57°C
Reagent Volume/1 Ojuil reaction Volume/600nl reaction
10X Reaction buffer 1 ul 60 yi\
Taq Polymerase 0.08 ^l 4.8 [i\
dNTP (10mM) 0.2 nl 12 |al
BSA (20 mg/ml) 0.125 (il 7.5 yi\
Primer Forward 1 nl 60 nl
Primer Reverse 1 nl 60 nl
Sybr Green (1:10 000) 0.33 jal 19.8 nl
MgCI2 0.4 nl 24 ul
cDNA 1 nl 60 nl
Water 5.865 ^l 351.9 nl
Total 10 jJ 600 nl
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2.6.2 Generation of coefficient files
Standard curves for the house-keeping gene, PBGD, and for the target genes 
(Pdx-1, Pax 4, GLUT-2 and GK) were constructed using cDNA from weanling 
control tissue (Group 10), and the relative expression of the genes was quantified 
from the unknown samples using these standard curves. The ratio of target gene 
expression to reference PBGD gene was used to derive the relative changes in 
gene expression of the target genes in the different samples. Coefficient files 
were used to perform the ratio calculation (as the reference and target gene are 
amplified in the same PCR reaction).
Normal control weanling cDNA (Group 10) was used throughout as a calibrator 
for all of the LightCycler experiments. The concentration of the cDNA was 
determined using a spectrophotomer (Perkin Elmer Instruments, Lambda 25 
UV/VIS, Wellesley, MA, USA), then dilutions of 1000 ng, 500 ng, 100 ng and 50 
ng were done in duplicate for Pdx-1, Pax 4, GLUT-2 and GK, with PBGD also 
done in duplicate for each primer pair. The LightCycler PCR (Roche Diagnostics, 
Mannheim, Germany) was then done at the respective annealing temperatures 
for each primer set.
2.6.3 Analysis of gene expression (Measurement of mRNA expression)
After quantification of the genes by LightCycler PCR using RelQuant (Roche 
Diagnostics, Mannheim, Germany), the control measurements were subtracted 
and taken arbitrarily as 1. Any sample reading over 1 was taken as
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overexpression, with readings under 1 representing underexpression of the 
particular gene.
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2.7.1 Tissue preparation and sectioning
The pancreas was excised from neonate and weanling rats, placed in 4% 
paraformaldehyde overnight and processed in an automated tissue processor 
(Shandon Citadel 1000, Cheshire, UK) through ascending concentrations of 
ethanol from 70% - 100%, followed by xylene. The tissue was embedded in 
paraffin wax (Paraplast Plus, Monoject Scientific Inc., St Louis, MO, USA). 
Sections, 4 |iim thick, were cut on a rotary microtome and mounted on slides 
coated with 3-aminopropyltriethoxysilane (APES). For histological examination, 
one slide per pup was placed in an oven at 60°C for 30 min, dewaxed with 
xylene, and rehydrated through a descending series of ethanol. Sections stained 
with haematoxylin and eosin were examined for morphological changes.
2.7.2 Immunohistochemistry
Slides of serial sections, not stained for histology, were transfered to 50 mM Tris- 
buffered saline (TBS), pH 7.4, in a staining jar and were immunostained using 
avidin D-biotinylated horseradish H complex (Vectastain, Vector Laboratories 
Inc., Burlingame, CA, USA). Briefly, the sections were incubated as follows 
(Table 8):
(1) 0.228% periodic acid in dH20  for 5 min,
(2) TBS for 10 minute wash,
(3) 1:20 diluted normal goat serum (NGS; MRC Delft animal facility, Cape Town, 
South Africa) for 20 min,
Immunohistochemical analysis
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(4) primary antibody (Pdx-1, GLUT-2 or GK),
(5) TBS for 10 minute wash,
(6) rabbit biotinylated antibody (Vectastain) for 30 min,
(7) TBS for 10 minute wash,
(8) avidin D-biotinylated horseradish H complex (Vectastain) for 60 min.
The peroxidase marker was revealed by incubating the sections for 5 min in a 
0.05% enzyme substrate solution of diaminobenzidine tetrachloride (DAB) 
(Sigma, St Louis, MO, USA) containing 0.01% hydrogen peroxide. The sections 
were counterstained in haematoxylin for 1 min. Method controls involved 
replacement of the primary antiserum with NGS.
The above protocol was standardized for GLUT-2 where 1:100 rabbit anti-rat 
GLUT-2 (WAK-Chemie, Bad Soden, Germany) was applied for 30 min as the 
primary antibody. For Pdx-1 (kindly donated by Prof C. Wright, Department of 
Cell Biology, Vanderbilt University Medical Center, Nashville, TN, USA) and GK 
(a kind gift from Dr H. Vertigan, CVGI Discovery Department, AstraZeneca, 
Cheshire, UK)) immunostaining, the protocol was repeated with an additional 
step of microwaving slides for 20 min and allowing them to cool to RT before 
applying NGS. Pdx-1 was diluted 1:1500, GK was diluted 1:1000 and DAB was 
added for only 2 min, instead of 5 min, for the GLUT-2 experiments.
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Table 8 Immunohistochemistry protocol
Step Protocol Duration
1 Dewax slides
2 50mM Tris buffer in staining jar 20 min
3 Microwave* 20 min
4 Cool at RT* 30 min
5 NGS 1/20 on slides in moisture chamber 20 min
6 Blot excess serum. Primary antiserum on slides in moisture 
chamber**
30 min
or overnight**
7 Jet wash 50mM Tris: 50mM Tris buffer in staining jar 10 min
8 Make vectastain
9 Biotinylated Ab on slides in staining jar 30 min
10 Jet wash Tris 50mM: 50mM Tris buffer in staining jar 10 min
11 Vectastain on slides in moisture chamber 60 min
12 Jet wash 50mM Tris: 50mM Tris buffer in staining jar 10 min
13 0.05% DAB + 0.01% H2O2 in 0.05M Tris on slides 2-5 m in t
14 Jet wash tap water: tap water wash in staining jar 5 min
15 Counterstain and mount
*Microwave and cooling down, steps 3 and 4, were only applicable for Pdx-1 and 
GK. These steps were omitted for GLUT-2.
**Pdx-1 and GK were incubated overnight at 4°C; GLUT-2 was incubated for 30 
min at RT.
|D AB was applied for 2 min for both Pdx-1 and GK and 5 min for GLUT-2.
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2.8.1 Image analysis of pancreata immunostained for insulin (beta-cell) and 
glucagon (alpha-cell)
A Canon Powershot S40 digital camera (Canon, Tochigi, Japan) mounted on an 
Olympus BX60 light microscope (Olympus, Tokyo, Japan) attached to a personal 
computer was used to capture images. The camera focus, light intensity and 
image resolution were controlled remotely and the acquired images were 
transferred to the computer using Remote Capture Software from Canon. The 
final digitized images were all 768 X 1024 pixels. Using the X10 objective, 
images were acquired for alternate fields of view until the entire section was 
covered. For each field of view, the islets were captured using a X40 objective for 
nuclei counts. An islet was defined as a cluster of eight or more endocrine cells. 
Image Analysis was performed with the Leica Qwin Plus Software (Leica, 
Cambridge, UK).
Tissue parameters were measured using either the interactive option or by doing 
colour segmentation. Total tissue area was determined by adding the tissue 
measured in each field of view, using the interactive measurement option of the 
Leica Software. Total islet area, total alpha-cell area and total beta-cell area were 
determined by using colour segmentation and thresholding. The relative beta-cell 
volume was obtained by calculating the ratio between the area obtained by 
immunoreactive beta-cells and the area occupied by total islet cells. Beta-cell 
number was assessed by counting the number of beta-cell nuclei. Beta-cell size 
was calculated by dividing the measured beta-cell area by the number of beta­
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cell nuclei counted and expressed in pm2. The same procedure was used to 
estimate the alpha-cell volume, number and size. The ratio of beta-cell area to 
alpha-cell area (beta-cell:alpha-cell) was determined by dividing the total beta­
cell area measured by the total alpha-cell area measured.
2.8.2 Image analysis of pancreata immunostained for Pdx-1, GLUT-2 and 
GK (Measurement of protein expression)
Immunolabelled sections were viewed on a Zeiss Axioskop2 light microscope 
(Zeiss, Jena, Germany) linked to a Zeiss Axiocam digital camera system (Zeiss, 
Jena, Germany). Captured micrographs of the islets of Langerhans were 
morphometrically analysed using the Zeiss KS 300 release 3.0 image analysis 
software (Carl Zeiss Vision, Hallbergmoos, Germany). Data was exported to MS 
Excel 97 (Microsoft Corp., Bellevue, WA, USA) and statistically analysed by a 
Statistica package vers 6.1 (StatSoft Inc., Tulsa, OK, USA). All of the pancreas 
sections were scanned for antibody activity (Pdx-1, GLUT-2 or GK). The levels of 
immunolabelled antibody (Pdx-1, GLUT-2 or GK) in the control (Group 5 
neonates and Group 10 weanlings) were taken to equal 1, with immunoreactivity 
in the pups exposed to a maternal HFD expressed as a ratio of the control levels.
2.9 Statistical analysis
The data of each group were compared to the control data and reported as 
means ± SEM. Comparisons between the groups were analyzed using the one­
way analysis of variance (ANOVA) followed by Bonferroni’s multiple comparisons 
for significant tests. Significance was established at P < 0.05.
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CHAPTER 3 
RESULTS
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Mothers
Pregnant dams were exposed to a HFD for either the first (Group 1), second 
(Group 2), or third (Group 3) week of gestation while a fourth group was fed a 
HFD throughout pregnancy (Group 4). The control group (Group 5) was 
maintained on a standard laboratory diet. Before the virgin female Wistar rats 
were mated, there were no differences in any of the parameters measured. This 
eliminated bias in the monitoring of each parameter at the various time points 
during gestation. Data for each of the parameters were pooled for mothers fed 
the same diet during the same period of gestation. This provided a larger n value 
for statistical purposes. For example, the two groups of dams which provided 
offspring for Group 1 and Group 6, respectively, were both fed a HFD for the first 
week of gestation only. The only difference between the two was that the 
offspring from Group 1 dams were euthanased at birth, and those from Group 6 
dams were killed at weaning. However, this made no difference to data at birth 
which could therefore be pooled.
3.1 Maternal food intake
Maternal food consumption and body weight
Dams fed a HFD for any single week of gestation ingested more food in that 
week than in the weeks that they were maintained on a standard laboratory diet 
(Table 9). Group 2, Group 3 and Group 4 dams consumed significantly more 
food during the 21 days of gestation than the control dams.
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Table 9 Maternal food consumption and body weight during pregnancy
Food intake from day 1 to day 7
Control Group 1 Group 2 Group 3 Group 4
19.47 ±0.38 28.26 ± 0.42 * 19.82 ± 0.85 17.79 ±0.23 29.42 ±0.91 *
of pregnancy, g
Food intake from day 8 to day 14 19.32 ±0.69 17.54 ±1.54 29.4 ± 1.19* 21.16 ±0.74 30.06 ± 0.96 *
of pregnancy, g
Food intake from day 15 to day 21.72 ±0.89 21.62 ±0.56 21.25 ± 1.07 30.91 ± 1.41 * 28.39 ± 0.99 *
21 of pregnancy, g
Overall food intake throughout 20.17 ±0.45 22.47 ± 1.12 23.49 ± 1.10 * 23.29 ± 1.35 * 29.29 ± 0.55 *
pregnancy, g
Maternal weight before 203.9 ± 3.46 210.6 ±3.93 211.8 ±3.61 197.7 ±4.17 204.3 ±4.91
pregnancy, g
Maternal weight on day 7 of 218.7 ±2.67 237.9 ± 4.49 225 ± 3.70 211.3 ± 4.69 241.4 ± 3 .6 8 *
pregnancy, g
Maternal weight on day 14 of 236.9 ± 2.42 248.2 ± 4.79 253 ± 5.82 228.1 ±3.71 268.4 ± 4 .4 4 *
pregnancy, g
Maternal weight on day of birth, 
9
238.3 ± 2.80 229.1 ±7.81 236.6 ± 5.92 231 ±9.69 259.9 ±4.62 *
Data represent means ± SEM. Pregnant dams were fed a high fat (40% energy as fat) diet for either the first (Group 1), 
second (Group 2) or third (Group 3) week, or throughout (Group 4) gestation. Control mothers were maintained on a 
standard laboratory diet (10% fat), n = 8. *P < 0.05 versus control.
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3.2 Maternal weight
There were no significant differences between the weights of virgin Wistar rats 
before they were mated (Table 9). At days 7 and 14 of gestation and after giving 
birth, Group 4 dams were significantly heavier than the control dams.
3.3 Maternal blood glucose concentrations
Blood glucose concentrations were significantly higher on day 7 of pregnancy in 
Group 1 and Group 4 dams (Table 10). Group 2 and Group 4 dams had 
significantly raised glycaemia on gestational day 14. After giving birth, Group 3 
and Group 4 dams were hyperglycaemic.
3.4 Maternal serum insulin concentrations
No significant differences in the serum insulin concentrations were evident 
between experimental dams, fed a HFD during gestation, and the control dams 
(Table 10).
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Table 10 Maternal circulating glucose and insulin concentrations
Blood glucose concentrations
Control 
5.86 ± 0.38
Group 1 
6.76 ± 0.60
Group 2 
6.16 ±0.21
Group 3 
6.18 ±0.42
Group 4 
6.36 ± 0.23
before pregnancy, mmol/l 
Blood glucose concentrations on 6.61 ±0.41 6.86 ± 0.42 * 6.15 ± 0.18 7.1 ±0.43 7.04 ± 0.32 *
day 7 of pregnancy, mmol/l 
Blood glucose concentrations on 5.51 ±0.29 5.07 ±0.19 5.81 ± 0 .1 5 * 5.41 ±0.27 5.55 ± 0 .1 5 *
day 14 of pregnancy, mmol/l 
Blood glucose concentrations on 5.91 ±0 .28 6.57 ±0.27 5.76 ±0.212 6.9 ±0.31 * 6.74 ±0.21 *
day of giving birth, mmol/l 
Serum insulin concentrations 126.6 ±25.34 74.56 ± 20.26 135.9 ±68.01 67.15 ±9.06 176.5 ±82.16
before pregnancy, pM
Serum insulin concentrations on 173.7 ±78.96 137.5 ±36.5 55.05 ± 15.89 152 ±40.84 217.7 ±32.58
day 7 of pregnancy, pM 
Serum insulin concentrations on 166.4 ±60.83 91.84 ±21.25 229.1 ± 57.69 97.13 ± 17.42 215 ±29.89
day 14 of pregnancy, pM 
Serum insulin concentrations on 152.1 ±40.82 178.8 ±54.41 81.78 ±23.1 169.7 ±42.2 155.9 ±25.62
day of giving birth, pM
Data represent means ± SEM. Pregnant dams were fed a high fat (40% energy as fat) diet for either the first (Group 1), 
second (Group 2) or third (Group 3) week, or throughout (Group 4) gestation. Control mothers were maintained on a 
standard laboratory diet (10% fat), n = 8. *P < 0.05 versus control.
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3.5 Optimization of GLUT-2 PCR conditions
A titration of different concentrations of MgCI2 for GLUT-2 was performed and the 
products revealed by gel electrophoresis (Figs. 3a and b). A concentration of 1.5 
mM MgCI2was in the standard PCR mix. The addition of an extra 1.0 mM MgCb, 
to give a final concentration of 2.5mM MgCI2was found to be optimal for RT-PCR 
experiments with GLUT-2.
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1 2 3 4 5 6 7 8
Fig. 3a Agarose (1%) gel electrophoresis for PCR optimization of GLUT-2 
using 0 mM MgCI2 and 0.5 mM MgCI2
Lanes 1-4: Four random rat pancreata cDNA samples were loaded without 
MgCl2.
Lanes 5-8: The same samples loaded with an additional 0.5 mM MgCh.
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Fig. 3b Agarose (1%) gel electrophoresis for PCR optimization of GLUT-2 
using 1.0 mM MgCI2 and 1.5 mM MgCI2
Lanes 1-4: Four random rat pancreata cDNA samples were loaded with and 
additional 1.0 MgCI2.
Lanes 5-8: The same samples loaded with an additional 1.5 mM MgC^.
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Neonates
3.6 Birth weights
Group 1 neonates had significantly decreased birth weights compared to the 
control (Fig. 4). The birth weights of neonates from the other experimental groups 
did not differ significantly from the control.
3.7 Plasma glucose concentrations in neonatal rats
Glucose concentrations were significantly lower in Group 1 and Group 2 
neonates compared to the control (Fig. 5). Group 4 neonates had significantly 
high glucose concentrations. No significant differences in glucose concentrations 
were found in Group 3 neonates.
3.8 Serum insulin concentrations in neonatal rats
No significant differences were found in the insulin concentrations in any of the 
neonates (Fig. 6).
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6.5
Control Group 1 Group 2 Group 3 Group 4
Fig. 4 Birth weights of neonatal rats
Birth weights of neonates exposed to an in utero HFD. Data represent mean ± 
SEM. n = 6. *P < 0.05.
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12.0
Control Group 1 Group 2 Group 3 Group 4
Fig. 5 Blood glucose concentrations in neonatal rats
Circulating glucose concentrations in neonates exposed to an in utero HFD. Data 
represent mean ± SEM. n = 6. *P < 0.05.
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200
180
Control Group 1 Group 2 Group 3 Group 4
Fig. 6 Serum insulin concentrations in neonatal rats
Circulating insulin concentrations in neonates exposed to an in utero HFD. Data 
represent mean ± SEM. n = 6.
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3.9 Effects of an in utero HFD on beta-cell development in neonatal rats
Group 4 neonates had significantly reduced beta-cell volumes (Fig. 7a). 
However, no significant differences were found in the beta-cell volumes of 
neonates exposed to a maternal HFD for any single week of gestation. Beta-cell 
number declined significantly in Group 1, Group 3 and Group 4 neonates (Fig. 
7b). No significant differences were found in the beta-cell sizes in any of the 
neonates (Fig. 7c).
3.10 Effects of an in utero HFD on alpha-cell development in neonatal rats
Group 4 neonates had a significantly greater alpha-cell volume (Fig. 8a). There 
were no significant differences in the alpha-cell volume of neonates exposed to a 
maternal HFD for a single week of gestation. The alpha-cell number was greater 
in Group 4 neonates (Fig. 8b). Alpha-cell size increased in Group 1, Group 3 and 
Group 4 neonates (Fig. 8c).
3.11 The effect of an in utero HFD on the beta-celi:alpha-cell ratio in 
neonatal rats
No significant differences were found in the beta-cell:alpha-cell ratio (Fig. 9).
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90
Control Group 1 Group 2 Group 3 Group 4
Fig. 7a The effects of exposure to an in utero high fat diet on beta-cell 
volume in neonatal rats
Beta-cell volume in neonates exposed to a maternal HFD. Data represent mean 
± SEM. n = 6. *P < 0.05.
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Fig. 7b The effects of exposure to an in utero high fat diet on beta-cell 
number in neonatal rats
Beta-cell number in neonates exposed to an in utero HFD.
Control Group 1 Group 2  Group 3  Group 4
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Control Group 1 Group 2 Group 3 Group 4
Fig. 7c The effects of exposure to an in utero high fat diet on beta-cell size 
in neonatal rats
Beta-cell size in neonates exposed to an in utero HFD.
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Control Group 1 Group 2 Group 3 Group 4
Fig. 8a The effects of exposure to an in utero high fat diet on alpha-cell 
volume in neonatal rats
Alpha-cell volume in neonates exposed to an in utero HFD. Data represent mean 
± SEM. n = 6. *P < 0.05.
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Control Group 1 Group 2 Group 3 Group 4
Fig. 8b The effects of exposure to an in utero high fat diet on alpha-cell 
number in neonatal rats
Alpha-cell number in neonates exposed to an in utero HFD.
74
Stellenbosch University http://scholar.sun.ac.za/
45
*
E
r  25
%20 iz 
Q.<
15
Group 1 Group 2 Group 3 Group 4
Fig. 8c The effects of exposure to an in utero high fat diet on alpha-cell size 
in neonatal rats
Alpha-cell size in neonates exposed to an in utero HFD.
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Control Group 1 Group 2 Group 3 Group 4
Fig. 9 The effects of exposure to an in utero HFD on the beta-cell:alpha-cell 
ratio in neonatal rats
Beta-cell:alpha-cell ratio in neonates exposed to an in utero HFD. Data represent 
mean ± SEM. n = 6.
76
Stellenbosch University http://scholar.sun.ac.za/
3.12 The effect of a HFD on Pdx-1 expression in neonatal rats
3.12.1 Pdx-1 mRNA expression in neonatal rats
Relative quantitative PCR showed no significant differences in the mRNA 
expression profiles for Pdx-1 in any of the experimental neonatal groups (Fig. 
10). There was, however, an almost significant increase (p = 0.057) in Pdx-1 
mRNA expression levels in Group 4 neonates compared to the control.
3.12.2 Pdx-1 immunoreactivity in neonatal rats
Light microscopy revealed Pdx-1 immunostaining to be intense and nuclear in 
the beta-cells of all of the neonatal sections (Fig. 11). Several of these beta-cells 
were scattered throughout the islets. Significant reduction in immunoreactivity for 
Pdx-1 was only observed in Group 2 and Group 4 neonates (Fig. 12). HFD 
exposure for the first of final week of gestation seemed to have no effect on 
immunoreactivity for Pdx-1 in neonatal rats.
3.13 The effect of a HFD on Pax 4 expression in neonatal rats
3.13.1 Pax 4 mRNA expression in neonatal rats
There were no significant differences evident in the mRNA expression levels of 
Pax 4 in any of the neonatal groups (Fig. 13). Although levels of Pax 4 mRNA 
were much higher than the control levels in Group 1 neonates, there was no 
significance because of the high degree of variance.
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4Group 1 Group 2 Group 3 Group 4
Fig. 10 Relative quantification of Pdx-1 mRNA in neonatal rats exposed to 
an in utero high fat diet
Pdx-1 mRNA expression in neonates exposed to an in utero HFD. Results for 
LightCycler PCR were normalized for Pdx-1 equalling 1. Data represent mean ± 
SEM. n =  10.
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Fig. 11 Immunohistochemical staining for Pdx-1 in the pancreata of 
neonatal rats exposed to a maternal high fat diet during specific periods of 
gestation
Pdx-1 immunolabelling in neonates exposed to a maternal HFD for the first (A; 
Group 1), second (B; Group 2) or third (C; Group 3) week, or throughout 
gestation (D; Group 4). The control represents neonates exposed to a standard 
laboratory diet through gestation (E; Control). X400.
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1.2
Fig. 12 Assessment of Pdx-1 immunolabelling by image analysis in 
neonatal rat pancreata exposed to an in utero high fat diet
Pdx-1 immunoreactivity in neonates exposed to an in utero HFD. The levels of 
immunolabelled Pdx-1 in the control neonates were taken to equal 1, with 
immunoreactivity in neonates exposed to an in utero HFD expressed as a ratio of 
the control levels. Data represent mean ± SEM. n = 6. *P < 0.05.
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Control Group 1 Group 2 Group 3  Group 4
Fig. 13 Relative quantification of Pax 4 mRNA in neonatal rats exposed to 
an in utero high fat diet
Pax 4 mRNA expression in neonatal rats exposed to a maternal HFD. Results for 
LightCycler PCR were normalized for Pax 4 equalling 1. Data represent mean ± 
SEM. n =  10.
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3.14 The effect of a HFD on GLUT-2 expression in neonatal rats
3.14.1 GLUT-2 mRNA expression in neonatal rats
There were no significant differences in the GLUT-2 mRNA levels in any of the 
experimental groups (Fig. 14), with the lowest levels detected in Group 2 
neonates.
3.14.2 GLUT-2 immunoreactivity in neonatal rats
Compared with the normal dense GLUT-2 immunostaining found in the beta-cell 
plasma membrane of control (Group 5) neonates (Fig. 15E), there was reduced 
intensity of GLUT-2 immunolabelling in neonates exposed to a HFD during each 
week of gestation (Fig 15A-C), with the lowest intensity in those exposed to a 
HFD throughout gestation (Fig. 15D). There were no significant differences in the 
GLUT-2 immunoreactive levels in any of the neonates (Fig. 16).
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Fig. 14 Relative quantification of GLUT-2 mRNA in neonatal rats exposed to 
an in utero high fat diet
GLUT-2 mRNA expression in neonates exposed to an in utero HFD. Results for 
LightCycler PCR were normalized for GLUT-2 equalling 1. Data represent mean 
± SEM. n = 10.
Control Group 1 Group 2  Group 3  Group 4
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Fig. 15 Immunohistochemical staining for GLUT-2 in the pancreata of 
neonatal rats exposed to a maternal high fat diet during specific periods of 
gestation
GLUT-2 mmunolabelling in neonates exposed to a maternal HFD for the first (A; 
Group 1), second (B; Group 2) or third (C; Group 3) week, or throughout 
gestation (D; Group 4). The control represents neonates exposed to a standard 
laboratory diet through gestation (E). X400.
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Fig. 16 Assessment of GLUT-2 immunolabelling by image analysis in 
neonatal rat pancreata exposed to an in utero high fat diet
GLUT-2 immunoreactivity in neonates exposed to an in utero HFD. The levels of 
immunolabelled GLUT-2 in the control neonates were taken to equal 1, with 
immunoreactivity in neonates exposed to an in utero HFD expressed as a ratio of 
the control levels. Data represent mean ± SEM. n = 6.
Control Group 1 Group 2  Group 3  Group 4
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3.15 The effect of a HFD on GK expression in neonatal rats
3.15.1 GK mRNA expression in neonatal rats
Group 1 neonates displayed significant underexpression of GK at mRNA (Fig. 
17). GK mRNA was maintained at normal expression levels in the other 
experimental groups.
3.15.2 GK immunoreactivity in neonatal rats
Only a few specific beta-cells showed immunoreactivity for GK (Fig. 18). These 
immunolabelled cells appeared to be mainly on the periphery of the islet. By 
means of image analysis, we found that Group 1 neonates had significantly 
increased immunoreactivity for GK (Fig. 19). However, Group 4 neonates had 
significantly reduced immunolabelling for GK. The remaining experimental 
groups (Group 2 and Group 3 neonates) had normal immunoreactivity for GK.
86
Stellenbosch University http://scholar.sun.ac.za/
Fig. 17 Relative quantification of GK mRNA in neonatal rats exposed to an 
in utero high fat diet
GK mRNA expression in neonates exposed to a maternal HFD. Results for 
LightCycler PCR were normalized for GK equalling 1. Data represent mean ± 
SEM. n =  10. *P <0.05 .
Control Group 1 Group 2  Group 3  Group 4
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Fig. 18 Immunohistochemical staining for GK in the pancreata of neonatal 
rats exposed to a maternal high fat diet during specific periods of gestation
GK immunolabelling in neonates exposed to a maternal HFD for the first (A; 
Group 1), second (B; Group 2) or (C; Group 3) third week or throughout gestation 
(D; Group 4). The control represents neonates exposed to a standard laboratory 
diet through gestation (E; Control). X400.
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Fig. 19 Assessment of GK immunolabelling by image analysis in neonatal 
rat pancreata exposed to an in utero high fat diet
GK immunoreactivity in neonates exposed to an in utero HFD. The levels of 
immunolabelled GK in the control neonates were taken to equal 1, with 
immunoreactivity in neonates exposed to an in utero HFD expressed as a ratio of 
the control levels. Data represent mean ± SEM. n = 6. *P < 0.05.
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Weanlings
3.16 Weights of 3-week-old weanlings
Group 6, Group 7, Group 8 and Group 9 weanlings were leaner, while Group 14 
weanlings were heavier at 3 weeks of age (Fig. 20). No differences were 
detected in the body weights of Group 11, Group 12, Group 13 and Group 15 
weanlings.
3.17 Blood glucose concentrations in weanling rats
Apart from Group 9 and Group 14 weanlings, hyperglycaemia was found in all of 
weanlings used in this study (Fig. 21).
3.18 Serum insulin concentrations in weanling rats
Hypoinsulinaemia was evident in weanlings exposed to a maternal HFD only 
during specific periods of gestation (Groups 6-9), all displaying similar circulating 
levels of insulin (Fig. 22). Furthermore, Group 11 and Group 14 weanlings were 
also hypoinsulinaemic.
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Control Group 6 Group 7 Group 8 Group 9 Group 11 Group 12 Group 13 Group 14 Group 15
Fig. 20 Body weight at 3 weeks in weanling rats
Body weights in weanlings exposed to a maternal HFD during gestation and/or 
lactation. Data represent mean ± SEM. n = 6. *P < 0.05.
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Control Group 6 Group 7 Group 8 Group 9 Group 11 Group 12 Group 13 Group 14 Group 15
Fig. 21 Blood glucose concentrations in weanling rats
Circulating glucose concentrations in weanlings exposed to a maternal HFD 
during gestation and/or lactation. Data represent mean ± SEM. n = 6. *P < 0.05.
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Control Group 6  Group 7  Group 8  Group 9  Group 11 Group 12 Group 13 Group 14 Group 15
Fig. 22 Serum insulin concentrations in weanling rats
Circulating insulin concentrations in weanlings exposed to a maternal HFD during 
gestation and/or lactation. Data represent mean ± SEM. n = 6. *P < 0.05.
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3.19 Effects of an in utero HFD on beta-cell volume, number and size in 
weanling rats
Data was only available for weanlings exposed to a maternal HFD during defined 
periods of gestation, followed by a standard laboratory diet for the entire duration 
of lactation (Groups 6-9). No significant differences were found in the beta-cell 
volume (Fig. 23a). However, in Group 6, Group 7 and Group 8 weanlings, both 
beta-cell number (Fig. 23b) and size (Fig. 23c) were reduced. No significant 
differences in either the beta-cell number or size were detected in Group 9 
weanlings.
3.20 Effects of an in utero HFD on alpha-cell volume, number and size in 
weanling rats
No significant differences in alpha-cell volume (Fig. 24a) or number (Fig. 24b) 
were detected in any of the weanling groups. However, alpha-cells were 
significantly smaller in Group 6, Group 7 and Group 8 weanlings (Fig. 24c). No 
differences in alpha-cell size were detected in Group 9 weanlings.
3.21 Effects of an in utero HFD on the beta-cell:alpha-cell ratio in weanling 
rats
The beta-cell:alpha-cell ratio did not change in any of the weanlings exposed to a 
HFD during of gestation (Fig. 25).
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Control Group 6 Group 7 Group 8 Group 9
Fig. 23a The effects of exposure to a maternal HFD on beta-cell volume in 
weanling rats
Beta-cell volume in weanling rats exposed to in utero HFD. Data represent mean 
± SEM. n = 6. *P < 0.05.
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Control Group 6 Group 7 Group 8 Group 9
Fig. 23b The effects of exposure to a maternal HFD on beta-cell number in 
weanling rats
Beta-cell number in weanlings exposed to an in utero HFD.
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Control Group 6 Group 7 Group 8 Group 9
Fig. 23c The effects of exposure to a maternal HFD on beta-cell size in 
weanling rats
Beta-cell sizes in weanlings exposed to an in utero HFD.
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Control Group 6 Group 7 Group 8 Group 9
Fig. 24a The effects of exposure to a maternal HFD on alpha-cell volume in 
weanling rats
Alpha-cell volume in weanlings exposed to maternal HFD. Data represent mean 
± SEM. n = 6. * P < 0.05.
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Fig. 24b The effects of exposure to a maternal HFD on alpha-cell number in 
weanling rats
Alpha-cell numbers of weanlings exposed to an in utero HFD.
Control Group 6  Group 7  Group 8  Group 9
99
Stellenbosch University http://scholar.sun.ac.za/
Control Group 6 Group 7 Group 8 Group 9
Fig. 24c The effects of exposure to a maternal HFD on alpha-ceil size in 
weanling rats
Alpha-cell sizes of weanlings exposed to an in utero HFD.
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Control Group 6 Group 7 Group 8 Group 9
Fig. 25 The effects of exposure to a maternal HFD on the beta-cell:alpha- 
cell ratio in weanling rats
The beta-cell:alpha-cell ratio in weanlings exposed to an in utero HFD. Data 
represent mean ± SEM. n = 6.
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3.22 The effect of a maternal HFD on Pdx-1 expression in weanling rats
3.22.1 Pdx-1 mRNA expression in weanling rats
Pdx-1 mRNA was overexpressed in Group 8 and Group 14 weanlings (Fig. 26). 
Pdx-1 mRNA was underexpressed in Group 15 weanlings. The expression 
profiles for mRNA in the remaining weanling groups, viz. Groups 6, 7, 9, 11-13, 
were all similar to the control.
3.22.2 Pdx-1 immunoreactivity in weanling rats
Nuclear staining of Pdx-1 was demonstrated in beta-cells throughout the islets 
(Figs. 27a and b). HFD exposure throughout any period of gestation and/or 
lactation did not seem to affect immunoreactivity for Pdx-1, as no significant 
differences were detected in the weanlings (Fig. 28).
3.23 The effect of a maternal HFD on Pax 4 expression
3.23.1 Pax 4 mRNA weanling rats
Significantly reduced Pax 4 mRNA levels were found in Group 6, Group 8, Group 
9 and Group 15 weanlings (Fig. 29). No differences were detected in the other 
weanling groups.
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Control Group 6  Group 7  Group 8  Group 9  Group 11 Group 12 Group 13 Group 14  Group 15
Fig. 26 Relative quantification of Pdx-1 mRNA in weanling rats exposed to a 
maternal high fat diet
Pdx-1 mRNA expression in weanlings exposed to a maternal HFD during 
gestation and/or lactation. Results for LightCycler PCR were normalized for Pdx- 
1 equalling 1. Data represent mean ± SEM. n = 10. *P < 0.05.
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Fig. 27a Immunohistochemical staining for Pdx-1 in the pancreata of 
weanling rats exposed to a maternal high fat diet during specific periods of 
gestation
Pdx-1 immunolabelling in weanlings exposed to a maternal HFD for the first (A; 
Group 6), second (B; Group 7) or third (C; Group 8) week of gestation, or 
throughout gestation (D; Group 9) followed by exposure to a standard laboratory 
diet during lactation. The control represents weanlings exposed to a standard 
laboratory diet throughout both gestation and lactation (E; Control). X400.
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Control Group 6 Group 7 Group 8 Group 9 Group 11 Group 12 Group 13 Group 14 Group 15
Fig. 28 Assessment of Pdx-1 immunolabelling by image analysis in 
weanling rat pancreata exposed to a maternal high fat diet
Pdx-1 immunoreactivity in weanlings exposed to a maternal HFD during 
gestation and/or lactation. The levels of immunolabelled Pdx-1 in the control 
weanlings were taken to equal 1, with immunoreactivity in weanlings exposed to 
an in utero HFD expressed as a ratio of the control levels. Data represent mean 
± SEM. n = 6.
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Control Group 6 Group 7 Group 8 Group 9 Group 11 Group 12 Group 13 Group 14 Group 15
Fig. 29 Relative quantification of Pax 4 mRNA in weanling rats exposed to a 
maternal high fat diet
Pax 4 mRNA expression in weanlings exposed to a maternal HFD during 
gestation and/or lactation. Results for LightCycler PCR were normalized for Pax 
4 equalling 1. Data represent mean ± SEM. n = 10. *P < 0.05.
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3.24.1 GLUT-2 mRNA expression in weanling rats
GLUT-2 mRNA was significantly underexpressed in Group 6, Group 11, Group 
12, Group 13, Group 14 and Group 15 weanlings (Fig. 30). Extremely low, but 
non-significant, levels of GLUT-2 mRNA were also detected in Group 7 and 
Group 8 weanlings. Although still lower than the control, a much higher 
expression level of GLUT-2 mRNA was found in Group 9 weanlings relative to 
the other experimental groups, but the differences were not significant.
3.24.2 GLUT-2 immunoreactivity in weanling rats
Intense immunostaining for GLUT-2, around the beta-cell membrane, was 
evident in weanlings exposed to a maternal HFD during any period of gestation 
and/or lactation (Figs. 31a and b). This immunolabelling was found throughout 
the islet in most of the beta-cells. Significantly raised GLUT-2 immunostaining 
was evident in Group 8, Group 9, Group 11, Group 12, Group 13, Group 14 and 
Group 15 weanlings (Fig. 32).
3.24 The effect of a maternal HFD on GLUT-2 expression in weanling rats
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Fig. 30 Relative quantification of GLUT-2 mRNA in weanling rats exposed to 
a maternal high fat diet
GLUT-2 mRNA expression in weanlings exposed to a maternal HFD during 
gestation and/or lactation. Results for LightCycler PCR were normalized for 
GLUT-2 equalling 1. Data represent mean ± SEM. n = 10. *P < 0.05.
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Fig. 31a Immunohistochemical staining for GLUT-2 in the pancreata of 
weanling rats exposed to a maternal high fat diet during specific periods of 
gestation
GLUT-2 immunolabelling in weanlings exposed to a maternal HFD for the first (A; 
Group 6), second (B; Group 7) or third (C; Group 8) week of gestation, or 
throughout gestation (D; Group 9) followed by exposure to a standard laboratory 
diet for the duration of weaning. The control represents weanlings exposed to a 
standard laboratory diet throughout both gestation and lactation (E; Control). 
X400.
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Fig. 31b Immunohistochemical staining for GLUT-2 in the pancreata of 
weanling rats exposed to a maternal high fat diet throughout gestation 
and/or for specific periods of lactation
GLUT-2 immunolabelling in weanling rats exposed to a maternal HFD throughout 
gestation and for either first (A; Group 11), the second (B; Group 12), or the third 
week of lactation (C; Group 13); or throughout gestation and lactation (D; Group 
14); or throughout lactation (E; Group 15). The control represents weanlings 
exposed to a standard laboratory diet throughout both gestation and lactation (F; 
Control). X400.
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Control Group 6 Group 7 Group 8 Group 9 Group 11 Group 12 Group 13 Group 14 Group 15
Fig. 32 Assessment of GLUT-2 immunolabelling by image analysis in 
weanling rat pancreata exposed to a maternal high fat diet
GLUT-2 immunoreactivity in weanlings exposed to a maternal HFD during 
gestation and/or lactation. The levels of immunolabelled GLUT-2 in the control 
neonates were taken to equal 1, with immunoreactivity in neonates exposed to 
an in utero HFD expressed as a ratio of the control levels. Data represent mean
Stellenbosch University http://scholar.sun.ac.za/
3.25.1 GK mRNA expression in weanling rats
The mRNA levels of GK were significantly reduced in Group 6, Group 7, Group 8, 
Group 12, Group 13, Group 14 and Group 15 weanlings (Fig. 33). GK mRNA 
levels were comparable to the control in Group 9 and Group 11 weanlings.
3.25.2 GK immunoreactivity in weanling rats
Similar to GK immunoreactivity in the neonatal rats, immunolabelling for GK was 
found in a few beta-cells on the periphery of the islet (Figs. 34a and b). In some 
of the islets, immunostained GK cells formed a circular border. The 
immunostaining for GK was intense in the sections. Significantly reduced 
immunoreactivity for GK was found in Group 6, Group 7, Group 8, Group 11, 
Group 12, Group 13, Group 14 and Group 15 weanlings (Fig. 35). GK 
immunoreactivity was normal, showing similar levels to the control in Group 9 
and Group 15 weanlings.
3.25 The effect of a maternal HFD on GK expression in weanling rats
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Fig. 33 Relative quantification of GK mRNA in weanling rats exposed to a 
maternal high fat diet
GK mRNA expression in weanlings exposed to a maternal HFD during gestation 
and/or lactation. Results for LightCycler PCR were normalized for GK equalling 
1. Data represent mean ± SEM. n = 10. *P < 0.05.
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Fig. 34a Immunohistochemical staining for GK in the pancreata of weanling 
rats exposed to a maternal high fat diet during specific periods of gestation
GK immunolabelling in weanlings exposed to a maternal HFD for the first (A; 
Group 6), second (B; Group 7) or third (C; Group 8) week, or throughout 
gestation (D; Group 9) followed by exposure to a standard laboratory diet for the 
duration of weaning. The control represents weanlings exposed to a standard 
laboratory diet throughout both gestation and lactation (E; Control). X400.
Stellenbosch University http://scholar.sun.ac.za/
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Fig. 34b Immunohistochemical staining for GK in the pancreata of weanling 
rats exposed to a maternal high fat diet throughout gestation and/or for 
specific periods of lactation
GK immunolabelling in weanling rats exposed to a maternal HFD throughout 
gestation and for either first (A; Group 11), the second (B; Group 12), or the third 
week of lactation (C; Group 13); or throughout gestation and lactation (D; Group 
14); or throughout lactation (E; Group 15). The control represents weanlings 
exposed to a standard laboratory diet throughout both gestation and lactation (F; 
Control). X400.
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Control Group 6 Group 7 Group 8 Group 9 Group 11 Group 12 Group 13 Group 14 Group 15
Fig. 35 Assessment of GK immunolabelling by image analysis in weanling 
rat pancreata exposed to a maternal high fat diet
GK immunoreactivity in weanlings exposed to a maternal HFD during gestation 
and/or lactation. The levels of immunolabelled GK in the control weanlings were 
taken to equal 1, with immunoreactivity in weanlings exposed to a maternal HFD 
expressed as a ratio of the control levels. Data represent mean ± SEM. n = 6. *P 
< 0.05.
117
Stellenbosch University http://scholar.sun.ac.za/
Fig. 27b Immunohistochemical staining for Pdx-1 in the pancreata of 
weanling rats exposed to a maternal high fat diet throughout gestation 
and/or for specific periods of lactation
Pdx-1 immunolabelling in weanling rats exposed to a maternal HFD throughout 
gestation and for either first (A; Group 11), the second (B; Group 12), or the third 
week of lactation (C; Group 13); or throughout gestation and lactation (D; Group 
14); or throughout lactation (E; Group 15). The control represents weanlings 
exposed to a standard laboratory diet throughout both gestation and lactation (F; 
Control). X400.
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Mothers
During early gestation, the mother develops hyperphagia which, together with 
endocrine changes, allows her to increase her net body weight, which is mainly 
due to the accumulation of fat depots in the first two thirds of gestation (134). 
This occurs in both in women and rats (134). In a study where 20-22 week old 
female Wistar rats were fed a moderately high fat (36% energy as fat) diet for 14 
weeks, the body weight and total energy intake, notably the dietary fat intake, 
increased significantly compared to those on the control (3% fat) diet (135). 
Earlier studies (136) also reported that a HFD can induce overconsumption and 
weight gain and the increased caloric intake due to the HFD would contribute to 
excess body weight. Similarly, our data indicate that the HFD was more palatable 
than the standard laboratory diet as pregnant dams consumed more food when 
maintained on a HFD. Dams fed a HFD for the second or third week of 
pregnancy or throughout gestation had higher overall food intakes after all 21 
days of gestation suggesting that, apart from the increase in food intake to 
ensure that their progeny grow and develop normally, a HFD given during the 
latter two weeks of gestation or throughout gestation induces greater overall food 
consumption in these pregnant dams. Dams used in our study, maintained on a 
HFD throughout pregnancy, were significantly heavier than those maintained on 
a standard laboratory diet at days 7 and 14 of pregnancy and on the day of 
delivery. This corresponded to the high food consumption of these dams at those 
time intervals of pregnancy which would have contributed to their gaining weight.
4.1 Maternal food intake and weight
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It has been reported that fat-rich diets may contribute to early weight gain not 
only because fat provides the substrate for triacylglycerol accumulation, but also 
because food intake increases as a result of the reduction in leptin secretion by 
adipose tissue (135).
Dietary fat induces overconsumption (137) and weight gain through its low satiety 
properties and high caloric density (136). A HFD promotes hyperphagia possibly 
related to palatability (138) and an attenuated satiety response to fat compared 
to carbohydrates (139-141) which may be related to postabsorptive factors such 
as stomach distension, nutrient absorption, hormonal release or oxidation of 
nutrients (138). Protein has been reported to be more satiating than carbohydrate 
(142-144) since high protein intake correlates with reduced overall food intake 
(144). Therefore, in terms of satiety potential, it appears that proteins are most 
effective, followed by carbohydrates, with the least satiation occurring with fat 
consumption.
Weight gain and feeding are mainly modulated by neural and hormonal inputs to 
the hypothalamus (145). In the study presented here, food consumption 
increased in the pregnant dams fed the HFD. On the day of delivery, the increase 
in body weight in Group 4 dams could be attributed to the increase in their overall 
food intake during pregnancy. While a high protein diet has a greater satiety 
effect than a HFD and turns off the feeding response, dams fed a HFD 
consumed more food ingesting higher dietary fat and protein than dams
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maintained on a standard laboratory diet. However the changes induced in the 
offspring (which will be discussed later) appear to be due to the high fat content 
of the diet. In addition, the energy derived from carbohydrate was reduced in the 
HFD. By increasing the fat component of the diet, the levels of the other 
macronutrients would be affected. The protein derived from calories was kept 
similar in both the HFD and standard laboratory diet as protein deficiency has a 
deleterious effect on islet cell development (29). Therefore the carbohydrate 
levels were reduced in the HFD which may be beneficial as high carbohydrate 
feeding has been shown to cause the immediate onset of hyperinsulinaemia in 
rats (146).
4.2 The effect of HFD feeding on maternal circulating glucose and insulin 
concentrations
In the study reported here, high fat feeding, in the week of pregnancy prior to the 
measurement of the circulating glucose concentrations in dams, induced acute 
hyperglycaemia which occurred only at that particular time point. This was 
evident in all dams fed a HFD for only a single week of gestation. In addition, 
dams fed a HFD throughout pregnancy were found to be hyperglycaemic at the 
two days (7 and 14) of pregnancy when blood glucose was measured. Similarly, 
on the day of delivery, both these dams and those fed a HFD for the final week of 
gestation were hyperglycaemic. Since dams that were fed a HFD throughout 
gestation remained hyperglycaemic at all the time intervals measured, and 
particularly on the day of giving birth it could be suggested that prolonged high fat
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feeding, in addition to the metabolic demands of pregnancy, induce 
hyperglycaemia.
Pregnancy induces profound changes in maternal metabolism and insulin 
secretion, both of which allow optimum nutrient supply to the foetus (147). 
Maternal insulin resistance normally develops in the last trimester in both women 
and rats (148; 149). In the study for this thesis, circulating insulin levels were 
measured on day 20 of pregnancy in some of the mothers. Although the insulin 
levels of dams fed a HFD during gestation did not differ significantly from the 
control, all of the insulin levels were higher than those detected in non-pregnant 
dams. Significantly higher insulin concentrations were found in dams fed a HFD 
for the first or second week of gestation or throughout gestation (data not shown) 
and this can be attributed to the reported hyperinsulinaemia associated with 
pregnancy in the final trimester. In addition, glucose concentrations in these 
dams on day 20 of pregnancy in these dams were normal, confirming that there 
was at least sufficient insulin in the circulation to maintain glucose homeostasis. 
The circulating insulin levels did not differ significantly in the dams during 
pregnancy or on the day of delivery, but were higher relative to those on a 
standard laboratory diet, when measured after the dams were fed a HFD.
Gestational diabetes is defined as any form of diabetes mellitus or impaired 
glucose tolerance with first onset during pregnancy (150). A rat model for 
gestational diabetes was developed in a recent study (151). The female rats
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were fed a cafeteria style diet, 4 weeks prior to mating, and this resulted in 
increased body weight that persisted throughout pregnancy (151). While 
pregnant, these rats exhibited impaired glucose tolerance with insulin resistance, 
as determined by hyperinsulinaemic clamp studies on day 22 of pregnancy (151). 
In another model of gestational diabetes, using uteroplacental insufficiency, 
pregnancy resulted in rats developing progressive hyperglycaemia and 
hyperinsulinaemia accompanied by impaired glucose tolerance and insulin 
resistance (152). These rats were also significantly heavier after gestation (152). 
Although hyperglycaemia was detected, after birth, in dams fed a HFD 
throughout gestation in the present study, the circulating insulin levels were 
comparable to the control. Unlike the previously described models of gestational 
diabetes, the insulin status appears to be normal which indicates that dams used 
in this study did not fully develop gestational diabetes. We conclude, therefore, 
that the changes induced in the offspring were mainly attributed to the pups 
being exposed to maternal HFD during critical periods of pancreatic development 
and growth possibly exacerbated by the maternal hyperglycaemia. The metabolic 
status of the mothers during pregnancy and lactation, however, was not the focal 
point of this study. The effects of high fat feeding on pregnant dams may 
however be determined in further studies taking into consideration their glucose 
and insulin responses.
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Neonates
Nutrition during the early phases of life is of major importance for proper tissue 
development and functional maturation (153). Programming is the process by 
which the physiology or metabolism of a foetus and/or neonate may be altered by 
a stimulus or insult during a critical period of development (154). During 
gestation, we exposed pups to a HFD, indirectly, through the mother. It is known 
that the diet, in utero, is critical to the development of the offspring. An in utero 
protein deficient diet has been shown to decrease birth weights in rats (31; 155). 
Women, undernourished in the first trimester of pregnancy, were found to 
produce offspring who were small at birth (154). Using a HFD instead of a low 
protein diet, in this thesis study, we have now found that dams fed a HFD for only 
the first week of gestation gave birth to pups with significantly reduced birth 
weights. It has been hypothesized that low birth weight predisposes the offspring 
to the development of Type 2 diabetes and insulin resistance syndrome in adult 
life (25). By extrapolation, pups exposed to a maternal HFD for the first week of 
gestation may therefore be susceptible to developing diabetes later in life. Foetal 
growth and development are determined primarily by the genetic potential of the 
foetus, but this can be influenced by environmental factors, such as the 
nutritional status of the mother and/or the capacity of the placenta to transport 
these nutrients to the foetus (26). Interestingly, pups that were exposed to a HFD 
for any other week of gestation, other than the first, or throughout gestation had 
normal birth weights.
4.3 The effect of an in utero HFD on birth weight
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Pregnancy results in profound changes in both maternal metabolism and insulin 
secretion to allow optimal nutrient supply to the foetus (147). Furthermore, the 
insulin demands on the mother, during pregnancy, dramatically increase due to 
enhanced insulin resistance of maternal tissues and increased food intake, and 
this occurs especially during the latter half of pregnancy (156). Our data showed 
that pregnant dams consumed more food when maintained on a HFD. It has 
been reported that foetal metabolism, and consequently foetal growth, directly 
depend on the nutrients crossing the placenta (134). The mother, therefore, must 
adapt her metabolism in order to support this continuous draining of substrates 
(134). The body weights and food consumption of dams, in this thesis study, fed 
a HFD for only the first week of gestation did not differ significantly from the 
control.
At critical periods of foetal and early life, certain metabolic processes can be 
programmed, for an organism to accommodate a particular level of nutrition 
throughout life, thus conferring a survival advantage (25). However, a 
subsequent improvement in nutrition, for example, can lead to obesity, diabetes 
and cardiovascular disease in adult life (157). Studies in a rat model fed a high 
carbohydrate diet have shown that, by switching the nature of calories from high 
fat to high carbohydrate, extensive adaptations at the molecular, cellular and 
biochemical levels occur in islets isolated from 12-day old rats (158;159). Our 
study suggests that Group 1 neonates expect to be fed the same diet (i.e. HFD) 
for life. A change to a standard laboratory diet after the first week of gestation
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and continued for the remainder of gestation, concomitant with reduced caloric 
intake from the dams, may contribute to the growth retardation in these offspring. 
Apart from being leaner, Group 1 neonates were hypoglycaemic with the lowest 
circulating insulin concentrations. A reduction in body weight has been 
associated with reduced glucose (160) and insulin (31) levels in rats fed a low 
protein diet. Furthermore, specific foetal hypoinsulinaemia is associated with 
intrauterine growth retardation in humans (161). We have now shown that a HFD 
fed to pregnant dams for the first week of gestation results in offspring with low 
birth weights and reduced glucose and insulin levels, similar to findings in low 
protein fed rats.
Interestingly, despite being heavier at term, Group 4 dams gave birth to Group 4 
neonates of normal weight. This appears to have set a specific growth trajectory 
in these offspring. The Group 4 neonates, similar to the control neonates, were 
only exposed to one type of diet without any dietary switch. Therefore the Group 
4 neonates expect to consume a HFD throughout life and adapt promptly which 
may account for their normal growth.
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4.4 The effect of exposure to an in utero HFD on circulating glucose and 
insulin levels, the expression of transcription factors, glucose sensing 
genes and islet cell development in neonatal rats
The pancreatic beta-cell is designed to synthesize, package and release insulin 
on demand in order to control blood glucose homeostasis (162). Unlike other cell 
types it is constantly monitoring the nutrient status of the organism (162). Insulin 
secretion is stimulated by intracellular signals derived from the metabolism of a 
variety of nutrients, the most important being glucose (162). In addition to 
signalling the beta-cell to secrete insulin, nutrient secretagogues, like glucose, 
also generate important signals required to regulate gene expression, protein 
biosynthesis and cell proliferation (162). Chronic exposure to FFA has been 
shown to decrease Pdx-1 transactivation of GLUT-2, GK and insulin genes in 
islets (132). Glucose stimulates proinsulin biosynthesis at both the translational 
and transcriptional level (163-165). In the study presented here, neonates were 
exposed to a maternal HFD during defined periods of gestation. We therefore, 
related the circulating glucose levels to expression levels of the glucose 
transporter, GLUT-2, and the glycolytic enzyme, GK, which are both important for 
glucose metabolism within the beta-cell, ultimately resulting in insulin secretion. 
Pdx-1 is reported to regulate the transcription of the GLUT-2 (63), GK (64) and 
insulin (62) genes, and therefore, indirectly, plays a role in GSIS. We therefore 
monitored the changes in circulating glucose and insulin levels associated with 
exposure to an in utero HFD and related this to the expression of the glucose 
sensing genes involved in GSIS, GLUT-2 and GK, and the transcription factor,
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Pdx-1. Pdx-1 is also important for endocrine cell differentiation and in maintaining 
the beta-cell phenotype. Another, transcription factor, Pax 4, is important for 
ensuring proper beta- and alpha-cell development. The expression levels of 
these transcription factors, therefore, were discussed in relation to islet cell 
development.
(i) Neonates exposed to an in utero HFD for the first week of gestation 
(Group 1)
Neonates that were exposed to a maternal HFD for the first week of gestation 
were hypoglycaemic, with the lowest, though not significant, serum insulin levels. 
Both Pdx-1 and GLUT-2 mRNA levels and immunoreactivity were normal. 
However, GK mRNA expression was significantly reduced, while GK 
immunoreactivity was significantly higher. This suggests that transcription of GK 
may have been compromised by the HFD but, in contrast, translation of GK into 
protein has been increased. Insulin secretion depends upon glucose metabolism 
and GK exerts nearly total control on the rate of glycolysis in the beta-cells (112). 
The unique kinetics of GK underlie the ability of these cells to sense and respond 
to fluctuations in plasma glucose concentration (108). Modelling of changes in 
GK activity, as well as studies of the effects of graded increases in the enzyme, 
have established that glucose phosphorylation is the key point of control for 
glycolytic flux in the beta-cell (109; 110). Consequently, even small changes in 
GK activity can be physiologically significant, since they directly affect the 
threshold for GSIS (108). In addition to reducing blood glucose concentration,
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overexpression of GK appears to prevent the development of Type 2 diabetes 
(108). Our results would support this claim since we found that increased 
immunoreactivity for GK reduced blood glucose concentrations in one-day-old 
neonates that were exposed to an in utero HFD for the first week of pregnancy. 
The increase in GK protein expression should therefore increase the rate of 
glycolysis within the beta-cell which, dependent on downstream components of 
GSIS, could result in an increase in insulin secretion. In another study, male GK 
locus transgenic mice, that were fed a HFD, were protected against the 
development of hyperinsulinaemia and hyperglycaemia, even though these 
animals were as obese as their nontransgenic littermates (111). This suggests 
that if GK activity could somehow be enhanced, it might be an effective strategy 
for treating diabetes.
This thesis research showed that beta-cell volume and size was unaltered in 
these offspring, but there were significantly fewer beta-cells. The Pdx-1 
expression levels were relatively normal. It is possible that the reduction in beta­
cell number may be due to underexpression of other transcription factors 
important for beta-cell development, and also, in part, to the exposure to the HFD 
for the first week of pregnancy. Although not significant, Pax 4 mRNA was 
overexpressed, and was indeed the highest of all the groups. This may account 
for the significantly larger alpha-cells, since Pax 4 is required for normal alpha­
cell development. Measuring the expression levels of Pax 4 immunoreativity in 
these neonates could endorse this finding.
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(ii) Neonates exposed to an in utero HFD for the second week of gestation 
(Group 2)
Neonatal rats exposed to a maternal HFD for the second week of gestation were 
hypoglycaemic. Glucose activates Pdx-1 through an insulin-dependent cell 
signalling pathway involving phosphotidylinositol 3-kinase, and the stimulation of 
this pathway leads to phosphorylation and activation of a cytoplasmic form of 
Pdx-1 that translocates to the nucleus (73). In a recent study, a decrease in 
circulating glucose, in rats exposed to a low protein diet, was suggested to 
contribute to the reduced Pdx-1 expression, indicating that a low protein diet 
during the foetal (and lactation periods) could lead to alterations in islet size and 
functionality (31). These effects were linked to a reduction in Pdx-1 protein, but 
not Pdx-1 mRNA expression (31). Similarly, in our study, hypoglycaemia may 
have induced the reduction of Pdx-1 protein expression when foetuses were 
exposed to an in utero HFD for the second week of gestation. The serum insulin 
levels of these offspring were also reduced, though not significantly. The 
expression of Pdx-1 mRNA in these offspring was normal but there was a 
significant reduction in Pdx-1 immunoreactivity, concomitant with lowest, though 
not significant, expression of GLUT-2 mRNA detected. Pdx-1 is known to 
regulate transcription of the GLUT-2 gene, and the reduced Pdx-1 protein 
expression appears to impair the expression of GLUT-2 mRNA. However, the GK 
expression, at both mRNA and protein levels, was normal and therefore 
appeared to be unaffected by the reduced levels of Pdx-1 protein.
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The reduction in Pdx-1 immunoreactivity does not seem to affect beta-cell 
development as the beta-cell volume, number and size appeared to be normal. 
Pax 4 mRNA was overexpressed in these offspring, though not significantly, but 
this may have been sufficient to ensure normal beta-cell development, despite 
the reduced Pdx-1 immunoreactivity. In addition, normal alpha-cell development 
has also been maintained in these offspring.
(iii) Neonates exposed to an in utero HFD for the third week of gestation 
(Group 3)
Normal circulating glucose and insulin levels, similar to the control levels, were 
found in neonates that were exposed to a maternal HFD for the third week of 
gestation. This appeared to be attributed to normal expression profiles of the 
glucose sensing genes, GLUT-2 and GK, both in terms of mRNA levels and 
immunoreactivity. In addition, Pdx-1 mRNA expression and immunoreactivity was 
normal. GSIS seemed to be intact, possibly be due to similarity in GK expression 
profiles to the control levels (both mRNA expression and immunoreactivity), to 
ensure normal glycolysis. The normal Pdx-1 expression may also have played a 
role in ensuring the normal regulation of the GK and insulin genes.
These neonates were exposed to a HFD during the final week of gestation, which 
is reportedly the most quantitatively important phase of islet histogenesis (24). 
The rapid increase in islet cell mass that occurs in the rat in late foetal and early 
neonatal life may explain why pancreatic morphology is so sensitive to nutritional
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insult at this time (158). Since the expression of Pdx-1 (mRNA and 
immunoreactivity) and Pax 4 mRNA were normal, the reduced beta-cell number 
in these offspring appeared to be dietary-induced. It is interesting that alpha-cells 
were significantly larger, and, since Pax 4 mRNA levels were normal, this effect 
on alpha-cells may be attributed either to changes in Pax 4 protein expression or 
to other transcription factors involved in alpha-cell development. An important 
transcription factor involved in alpha-cell development is Pax 6. Pax 6, which is 
strongly related to Pax 4, is also required for normal endocrine pancreatic 
development and both of these transcription factors are required for endocrine 
cell differentiation (78).
(iv) Neonates exposed to an in utero HFD throughout pregnancy (Group 4)
An earlier study demonstrated that when adult rats were fed a HFD (40% of 
energy as fat) for 4-21 weeks, plasma glucose concentrations in both fasting and 
postprandial conditions were higher than in rats fed a low fat diet (5% energy as 
fat) (166). In our study, we found that exposure of foetuses to a high fat (40%) 
diet throughout pregnancy resulted in raised blood glucose levels compared to 
animals on a control (10%) fat diet. This overt hyperglycaemia may have resulted 
from the exposure of these offspring to a maternal HFD for the entire duration of 
pregnancy. These Group 4 neonates also had the highest circulating insulin 
levels relative to neonates that were exposed to an in utero HFD for a single 
week of gestation. Immunoreactivity for both Pdx-1 and GLUT-2 was reduced, 
which was significant in Pdx-1 and lowest for GLUT-2 relative to the other
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experimental groups. With less Pdx-1 protein available to transactivate GLUT-2 
gene expression, the resultant decreased availability of GLUT-2 on the beta-cell 
membrane may impair glucose uptake into the beta-cell for metabolism. In 
addition, the GK immunolabelling was reduced, and appears to have contributed 
to the hyperglycaemia evident in these neonatal rats by reducing the rate of 
glycolysis. Although, the Pdx-1 mRNA levels were almost significantly increased 
(p = 0.057), the Pdx-1 protein levels were, however, significantly reduced. These 
neonates may be trying to compensate for their hyperglycaemia by increasing 
their Pdx-1 mRNA output, but appear to be unable to translate mRNA into higher 
levels of Pdx-1 protein expression that would be required to maintain normal 
expression of the glucose sensing genes, GLUT-2 and GK, and insulin. 
Therefore, the reduced immunoreactivity for Pdx-1 may also have contributed to 
the hyperglycaemia.
Morphometric analysis of islets showed that beta-cell volume was significantly 
reduced in neonates that were exposed to an in utero HFD for the entire duration 
of pregnancy. Furthermore, counting the actual number of beta-cells revealed a 
significant decrease. It is interesting that, despite the compromised beta-cell 
development, these neonates displayed normal circulating insulin levels. 
Hyperglycaemia can result in decreased beta-cell mass by inducing apoptosis 
(167; 168). This may have played a role in the reduction of beta-cell volume in the 
case of neonates exposed to a HFD throughout pregnancy. In contrast, the 
alpha-cell volume, number and size appear to be stimulated by a HFD in utero
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and were all significantly increased in Group 4 neonates. Since these glucagon- 
secreting alpha-cells are functionally antagonistic to insulin, they could further 
stimulate glucose release into the circulation and therefore account for the 
hyperglycaemia in these neonates.
The significant reduction in Pdx-1 immunoreactivity as a result of exposure to a 
HFD appears, not surprisingly, to have compromised beta-cell development. In 
these offspring, alpha-cell development appears to be accelerated at the 
expense of the beta-cell. Apart from Pdx-1, Pax 4 is also required for normal 
beta-cell development. Interestingly, the Pax 4 mRNA levels were also reduced 
in these offspring (the lowest levels detected in all of the groups, but not 
significantly different from the control mRNA levels). Therefore reduced 
expression of the transcription factors, Pdx-1 (at the protein level) and Pax 4 (at 
mRNA level) appear to result in retarded beta-cell development. Unfortunately, 
Pax 4 protein levels were not measured as no commercial antibody was 
available at the start of this study. This would provide further insight into the role 
of Pax 4 in beta-cell development in offspring that were exposed to an in utero 
HFD. Furthermore, the expression levels of other transcription factors that are 
important for beta-cell maturation, such as Nkx 2.2 and Nkx 6.1, as well as Pax 
6, which is involved in alpha-cell development, should be determined in future 
studies to further our knowledge of the effects of an in utero HFD on islet cell 
development. Immunohistochemical studies using antibodies directed against
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somatostatin and pancreatic polypeptide would be useful to show us how this in 
utero HFD also affects the delta and pancreatic polypeptide cells respectively.
4.5 Summary of the effects of exposure to an in utero HFD on GSIS in 
neonatal rats
It has been reported that after being fed a high energy diet (2.93 Kcal/g), 
hyperglycaemic and hyperinsulinaemic rats (Psammomys obesus) showed a 
71% (after 1 week) and 94% (after 3 weeks) decrease in GLUT-2 
immunostaining on the beta-cell membrane (101). It is interesting that a reduction 
in GLUT-2 immunoreactivity was found in the hyperglycaemic Group 4 neonates, 
which develops from exposure to an in utero HFD throughout gestation.
Another study using a clonal beta-cell line to investigate the impact of glucose 
levels on Pdx-1 expression in pancreatic beta-cells, showed that chronic 
hyperglycaemia inhibited Pdx-1 mRNA and protein expression (76). In the study 
presented here, only neonates that were exposed to a HFD throughout gestation 
were hyperglycaemic at birth. Although hyperglycaemia may have played a role 
in the reduced Pdx-1 protein expression, at mRNA level, these offspring had 
higher expression levels of Pdx-1. The differences modulation in Pdx-1 mRNA 
levels can be attributed to differences in in vivo and in vitro models. In our study, 
the pups were not exposed to chronic hyperglycaemia, but hyperglycaemia 
appears to be a consequence of the in utero HFD exposure.
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It has been reported that normal Pdx-1 expression is required in mature beta- 
cells to maintain insulin production, GLUT-2 expression and glucose 
homeostasis (75). Furthermore, Pdx-1 has been reported to regulate the 
expression of GLUT-2 in a dosage dependent manner suggesting that lowered 
Pdx-1 activity may contribute to the development of Type 2 diabetes by causing 
impaired expression of both GLUT-2 and insulin (75). In another study, early loss 
of GLUT-2 expression was shown to be involved in the development of 
hyperglycaemia in Pdx-1 beta-cell-specific mutants and that the combined loss of 
GLUT-2 and gradual decrease of insulin expression together was found to lead 
to the manifestation of diabetes (75). Thus lowered Pdx-1 expression or activity 
resulting in impaired expression of both GLUT-2 and insulin could cause 
hyperglycaemia which may progress to Type 2 diabetes (75). In this thesis study, 
the neonates exposed to an in utero HFD throughout pregnancy, had lowered 
immunoreactivity for Pdx-1 and GK which therefore appears to have contributed 
to the development of hyperglycaemia. A recent study in MIN6 beta-cells showed 
that inhibition of GSIS through the inactivation of IGF-1R, resulted in elevated 
glucose concentrations which regulate preproinsulin, Pdx-1 and GK gene 
expression in beta-cells (74). These studies showed that released insulin, acting 
via IR, is likely to be an important mediator of the effects of glucose on Pdx-1 
gene expression in normal MIN6 beta-cells (74). However, insulin-independent 
mechanisms were sufficient to allow the control by glucose of GK gene 
expression in wild type cells and regulation of the Pdx-1 gene in the absence of 
IGF-1R (74). Although the insulin levels in the offspring of our study were normal
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(only slightly raised) at this stage, the reduced Pdx-1 and GK immunoreactivity, 
concomitant with the hyperglycaemia, suggests that the Group 4 neonates (that 
have been exposed to a maternal HFD throughout gestation) would be most 
susceptible (relative to the neonates exposed to a maternal HFD for only a single 
week of gestation) to develop Type 2 diabetes later in life if they are unable to 
maintain glucose homeostasis.
A HFD has been shown to decrease both GLUT-2 mRNA expression (34) and 
translocation to the plasma membrane (105). Reduced gene expression of 
GLUT-2 in beta-cells was also observed in neonatal rats treated with 
streptozotocin (96) and in Goto-Kakizaki diabetic rats (98). Other genetic models 
of diabetes such as Wistar Kyoto and Zucker diabetic rats (98; 102), which are 
hyperinsulinaemic and hyperglycaemic, express less GLUT-2. Now we have 
shown that GLUT-2 (although not significant), GK and Pdx-1 immunoreactivity is 
already reduced at birth in normal Wistar rats exposed to a maternal HFD 
throughout pregnancy.
4.6 Summary of the effects of exposure to an in utero HFD on islet cell 
development in neonatal rats
An in utero protein deficient diet in rats has been shown to reduce pancreatic 
islet size, islet vascularization and the number of beta-cells (27;28) We have 
previously shown, in adult Vervet monkeys, a reduction in beta-cell volume after 
maintenance on a HFD for 18 months (37). Mice, maintained on a high fat/high
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protein (HF/HP) diet or a HFD, showed a reduction in beta-cell mass, with 
increased apoptosis relative to proliferating beta-cells at 20 and 30 weeks of age 
(169). In rodent models of obesity without diabetes, there is an adaptive increase 
in beta-cell mass to meet the insulin demands (170). Studies suggest that beta­
cell mass is also adaptively increased in non-diabetic obese humans (171). Beta­
cell mass is regulated by a balance of beta-cell replication and apoptosis as well 
as development of new islets from exocrine pancreatic ducts (neogenesis) 
(172; 173). Disruption of any of the pathways of beta-cell formation or increased 
rates of beta-cell death would result in decreased beta-cell mass and this would 
reduce the capacity to produce insulin (174). Our data demonstrate compromised 
beta-cell development in neonates that were exposed to a HFD in utero and this 
suggests that either beta-cell replication pathways are being inhibited by a HFD 
during gestation, or that apoptosis in the beta-cells is being induced by the HFD, 
or both. In a study where adult CD-1 mice were injected with streptozotocin to 
induce hyperglycaemia, islets were shown to gradually lose their regenerative 
potential when exposed to high circulating glucose concentrations for an 
extended period of time (175). It may therefore be possible that the 
hyperglycaemia, evident in Group 4 neonates, may have inhibited neogenesis. 
Furthermore, increased duration of exposure to a HFD, as in Group 4 neonates, 
resulted in the most profound inhibition of beta-cell development relative to those 
neonates only exposed to a maternal HFD for a single week of gestation.
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This study demonstrated that in utero HFD exposure, for the first or final week of 
gestation, reduces beta-cell number in neonatal rats. It appears that the longer 
the period of HFD exposure in utero, the greater the inhibitory effect of the HFD 
on beta-cell development. This was evident in Group 4 neonates that were 
exposed to a HFD throughout pregnancy, resulting in a significant decrease in 
beta-cell volume and data suggesting it is due to there being significantly fewer 
beta-cells. A decrease in beta-cell number would result in an increase in the 
functional load for each individual beta-cell, thereby making the maintenance of 
glucose homeostasis harder to achieve. A decrease in beta-cell mass alone, 
except if it is severe, cannot cause diabetes because of the great reserve for 
insulin production of the endocrine pancreas (176). A reduced beta-cell mass 
would however be subjected to a persistently increased functional load, which, in 
the long term, may exhaust insulin release (176). Providing that beta-cell 
development is not normalized later in life, we speculate that beta-cell failure 
could develop in these animals.
Larger alpha-cells were found in neonates exposed to a maternal HFD for the 
first or final week of gestation. Furthermore, exposure to a maternal HFD 
throughout pregnancy not only resulted in larger alpha-cells, but also increased 
alpha-cell volume and number. The HFD, directly or indirectly, appeared to have 
a stimulatory effect on alpha-cell development. Earlier research reports that 
volume density of alpha-cells was significantly elevated, with both elevated 
pancreatic and plasma glucagon concentrations, in weanling female mice
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maintained on a high protein diet (177). The increase in alpha-cell volume 
density and pancreatic glucagon concentration appeared to be due initially to 
alpha-cell hypertrophy. The authors speculated that these changes were 
compensatory responses to the increased functional demand on alpha-cells (i.e. 
glucagon biosynthesis and secretion) imposed by chronic high-protein feeding
(177). In our study, it appears that exposure to a maternal HFD throughout 
pregnancy has induced alpha-cell hyperplasia and hypertrophy resulting in an 
increase in alpha-cell volume. Pdx-1 immunoreactivity, which was reduced in 
offspring exposed to a maternal HFD throughout gestation, appears to have 
resulted in compromised beta-cell development. We therefore speculate the HFD 
in utero may modulate the expression of key genes involved in alpha-cell 
development thereby resulting in accelerated alpha-cell growth. This concept 
needs to be investigated in further studies.
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In our study, Wistar weanling rats exposed to a HFD during defined periods of 
gestation followed by a standard laboratory diet after birth were leaner. This may 
be due to a decrease in the maternal food intake since pregnant dams consumed 
less food when fed a standard laboratory diet as opposed to the HFD. Foetal 
metabolism and foetal growth directly depend on nutrients crossing the placenta 
(134). Since foetal growth is largely determined by maternal nutrition, a lower 
food intake by the mother would be expected to retard growth in the offspring, 
particularly during pregnancy and lactation, as these are critical periods of growth 
in the offspring and in beta-cell development. A recent study reported that weight 
was significantly decreased in offspring exposed to a maternal low protein diet 
throughout gestation and lactation in 3-week-old weanling Wistar rats which 
persisted into adulthood even after the pups were fed a standard laboratory diet
(178). The lower body weights in the weanlings of our study correlates well with a 
study done in mice where body weight increased after high fat feeding, but 
decreased after low fat intervention (179). The marked reduction in body weight 
in low fat fed mice was attributed to the lower energy intake (179). During such 
critical periods, either stimulus or insult may have long-lasting consequences on 
tissue or organ function postnatally (180).
W eanlings
4.7 The effect of a HFD in utero, and during lactation, on the body weight of
weanling rats
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Exposure to a HFD is known to increase circulating levels of FFA. A HFD may 
therefore be detrimental to pancreatic development due to an excess, in the diet, 
of FFA, which apart from increasing body weight by the storage of accumulated 
fat, also compete with glucose for metabolism (44). A HFD can induce 
overconsumption and weight gain and the increased caloric intake due to high fat 
feeding would contribute to excess body weight (136). In a study where 20-22 
week old female Wistar rats were fed a moderately high fat (36% energy as fat) 
diet for 14 weeks, the body weight and total energy intake, notably the dietary fat 
intake, increased significantly compared to the control (3% fat) diet (135). Fat- 
rich diets may contribute to early weight gain not only because fat provides the 
substrate for triacylglycerol accumulation, but also because food intake increases 
as a result of the reduction in leptin secretion by adipose tissue (135). Indeed, 
those progeny exposed to a HFD throughout gestation and weaning were 
significantly heavier and if these rats became obese they could be at risk for the 
development of Type 2 diabetes mellitus. In contrast, weanlings that were 
exposed to a maternal HFD throughout gestation and only for a single week of 
lactation had normal body weights. Offspring exposed to a maternal HFD only 
throughout lactation also had normal body weights at 3 weeks. This shows that 
continuous exposure to a maternal HFD throughout both gestation and weaning 
results in heavier weanlings at 3 weeks.
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4.8 The effect of a HFD in utero and during lactation on circulating glucose 
and insulin levels, the expression of transcription factors, glucose sensing 
genes and islet cell development in weanling rats
(i) Weanlings exposed to an in utero HFD for the first week of gestation 
(Group 6)
Weanling rats, exposed to a maternal HFD for only the first week of gestation, 
were hyperglycaemic and hypoinsulinaemic. Although immunoreactivity for 
GLUT-2 was normal, the expression of GLUT-2 mRNA was significantly reduced. 
Furthermore, both GK mRNA and immunoreactivity were significantly reduced. 
GLUT-2 transports glucose into the beta-cell, whereby GK phosphorylates 
glucose ultimately resulting in insulin secretion. The reduction in these glucose 
sensing genes, GLUT-2 (at mRNA level) and GK (both mRNA expression and 
immunoreactivity), may therefore have contributed to both the hyperglycaemia 
and hypoinsulinaemia that was evident in these offspring. We speculate that less 
glucose would be transported into the beta-cell for metabolism by GLUT-2 and, 
with the reduced GK levels, the rate of glucose metabolism would decrease 
thereby resulting in reduced insulin secretion. Pdx-1 mRNA expression and 
immunoreactivity was normal in Group 6 weanlings. This suggests that Pdx-1 
may not be responsible for the reduced expression of the glucose sensing genes, 
and the ensuing hyperglycaemia and hypoinsulinaemia.
The beta-cell number and size was significantly reduced in weanlings exposed to 
a maternal HFD for the first week of gestation. The significantly reduced Pax 4
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mRNA levels detected in these offspring may, in part, explain the compromised 
beta-cell development and the smaller alpha-cell sizes, since Pax 4 is an 
important transcription factor that regulates endocrine cell development. In the 
Group 6 weanlings, Pdx-1 mRNA expression and immunoreactivity was normal, 
suggesting that it may not play a role in the compromised islet cell development.
(ii) Weanlings exposed to an in utero HFD for the second week of gestation 
(Group 7)
Hyperglycaemia and hypoinsulinaemia was evident in those offspring exposed to 
an in utero HFD only for the second week of gestation. Low levels of GLUT-2 
mRNA were detected (not significant) with immunoreactivity for GLUT-2 
appearing to be normal. However, GK mRNA was underexpressed and 
immunoreactivity for GK was reduced, both significantly. Pdx-1 mRNA 
expression and immunoreactivity was normal. We speculate that although 
glucose transport may be adequate (since GLUT-2 immunoreactivity was 
unaffected by the HFD intervention), the reduced GK expression, both mRNA 
expression and immunoreactive levels, may be responsible for reduced insulin 
secretion from the beta-cell. Furthermore, these low serum insulin levels are 
insufficient to stimulate glucose uptake into the peripheral tissues, therefore 
hyperglycaemia persists.
Significantly fewer beta-cells, that were also smaller when compared to the 
control, were found in Group 7 weanlings. Pdx-1 mRNA and immunoreactivity did
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not differ significantly from the control levels. However, the highest levels of 
immunolabelling for Pdx-1 were found in these offspring relative to all the 
experimental groups. This suggests that the pups may be attempting to improve 
beta-cell development.
(iii) Weanlings exposed to an in utero HFD for the third week of gestation 
(Group 8)
In weanlings exposed to an in utero HFD for only the third week of gestation, 
hyperglycaemia and hypoinsulinaemia was evident. GLUT-2 mRNA levels were 
reduced, though not significantly. However, the immunoreactivity for GLUT-2 was 
significantly increased. Both the GK mRNA expression and protein (determined 
by image analysis) levels were significantly reduced in these offspring. We 
postulate that GLUT-2 protein levels have been increased in response to 
hyperglycaemia in order to restore the plasma glucose levels to within the normal 
range. However, this compensatory mechanism is not yet effective as some 
defect in the glucose metabolism pathway seems to exist, resulting in low 
circulating insulin levels despite the hyperglycaemia. The reduced expression of 
GK (both at mRNA and protein level) appears to be the defect contributing to the 
reduced circulating insulin levels. With less GK available within the beta-cell, the 
rate of glycolysis would decrease, resulting in reduced metabolism of glucose. 
This may cause reduced GSIS from the beta-cell. It would be interesting to study 
each step of the GSIS pathway in order to determine whether any other 
components are affected by the HFD intervention. Another explanation may be
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that insulin may not be fully processed resulting in a high proinsulin/insulin ratio 
in the circulation. Further studies determining the insulin content and insulin 
secretion would provide further insight into changes that may occur metabolically 
in the beta-cell after exposure to a HFD. An approximate increase of 70% GLUT- 
2 protein content was found in islets from 12-day rats fed a high carbohydrate 
diet (146). A similar increase in GLUT-2 protein was reported in another study in 
islets of normoglycaemic and hyperinsulinaemic pregnant rats (181). We have 
now shown that, in weanling rats exposed to a maternal HFD for the final week of 
gestation, GLUT-2 protein levels were also significantly higher.
Pdx-1 mRNA was significantly overexpressed, with normal immunoreactivity for 
Pdx-1. It appears that the HFD may, in fact, have a stimulatory effect by 
increasing the mRNA levels of Pdx-1, but somehow this mRNA is not effectively 
translated into protein, perhaps due to some post-translational defect. 
Furthermore, Pdx-1 does not appear to have a role in the reduced expression of 
the glucose sensing genes. Therefore the reduction in both GK mRNA 
expression and immunoreactivity, and the hyperglycaemia and hypoinsulinaemia, 
may be largely due to the HFD.
Pax 4 mRNA was significantly reduced. This, along with the dietary exposure 
during the final week of gestation, may have caused the reduction in beta-cell 
number and resulted in the smaller beta- and alpha-cells, which may be via 
reduced differentiation of ductal cells into islet cells. The Pdx-1 mRNA was
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significantly increased and may be an indication that the animal is attempting to 
correct the compromised islet cell development by increasing the expression of 
this transcription factor which is not only important for beta-cell development from 
ductal cells, but also in the maturation of these insulin-producing cells.
(iv) Weanlings exposed to an in utero HFD throughout gestation (Group 9)
Circulating glucose levels were normal in weanling rats that were exposed to a 
maternal HFD throughout gestation. However, these pups were 
hypoinsulinaemic. Although the GLUT-2 mRNA levels in weanlings exposed to a 
HFD for the duration of pregnancy were reduced relative to the control, they were 
much higher compared to the other experimental groups (though not significant). 
GLUT-2 immunoreactivity, however, was significantly higher. It appears that 
glucose transport, via GLUT-2 compensatory overexpression at protein level, has 
succeeded in maintaining glucose homeostasis. However, the circulating insulin 
levels were significantly reduced. Both GK and Pdx-1 mRNA expression and 
immunoreactivity remained intact. It appears that the hypoinsulinaemia may be 
due mainly to the HFD because expression of GK and Pdx-1 was normal (both 
mRNA and immunoreactivity) in these weanlings.
Although the Pax 4 mRNA was significantly reduced in Group 9 weanlings, both 
beta-cell and alpha-cell development were normal. This may be explained by the 
normal expression of Pdx-1, which is considered the master regulator of beta-cell 
development and maintenance.
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(v) Weanlings exposed to a maternal HFD throughout gestation and for the 
first week of lactation (Group 11)
Weanlings exposed to a maternal HFD throughout pregnancy and continued into 
the first week of lactation, were hyperglycaemic and hypoinsulinaemic at 3 weeks 
of age. Although GK mRNA expression was highest amongst the experimental 
groups, it did not differ significantly from the control levels. However, 
immunoreactivity for GK was significantly lower. GLUT-2 overexpression at 
protein level (i.e. immunoreactivity), which would increase glucose transportation 
into the beta-cell, appears not to be adequate to reduce the circulating glucose 
levels, as hyperglycaemia persists in these offspring. This overexpression may 
be an adaptive response to reduced GK immunoreactivity, which would definitely 
play a role in inhibiting insulin secretion from the beta-cell, hence the 
hypoinsulinaemia. Pdx-1 mRNA expression and immunoreactivity profiles were 
similar to those of the control. The HFD intervention therefore appeared to have 
little effect on the gene expression of Pdx-1 or on the Pax 4 mRNA levels which 
were also normal.
(vi) Weanlings exposed to a maternal HFD throughout gestation and for the 
second week of lactation (Group 12)
Weanlings that were exposed to a maternal HFD for the entire duration of 
pregnancy, and for the second week of lactation, were hyperglycaemic, but had 
normal circulating insulin levels. GLUT-2 mRNA was reduced, but 
immunoreactivity for GLUT-2 was increased, both significantly. Both GK mRNA
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expression and immunoreactivity were significantly reduced. It appears that 
GLUT-2 overexpression at protein level is an adaptive response to reduce the 
hyperglycaemia. Despite the reduced levels of GK, insulinaemia remained intact. 
Pdx-1 mRNA expression and immunoreactivity, and Pax 4 mRNA expression 
were all normal. Since expression of Pdx-1 was normal, the regulation of the 
insulin gene should be normal, and is at this stage, sufficient to ensure normal 
circulating insulin levels. However, hyperglycaemia was evident, which may 
indicate that insulin may not be fully functional or perhaps not fully processed by 
the beta-cell. Measurement of proinsulin or C-peptide in these offspring would 
provide further insight.
(vii) Weanlings exposed to a maternal HFD throughout gestation and for 
the third week of lactation (Group 13)
Hyperglycaemia had developed in weanling rats exposed to a maternal HFD 
throughout gestation, and for the final week of lactation, but the circulating insulin 
levels remained normal. Expression for GLUT-2 was significantly reduced at 
mRNA level, but significantly upregulated at protein level. GK mRNA expression 
and immunoreactivity were both significantly reduced. The HFD appears to have 
induced hyperglycaemia and reduced gene expression of GK. GLUT-2 
overexpression at protein level appears to be an adaptive response, which is 
unsuccessful for effective glucose clearance and transport into the beta-cell. No 
significant differences were found in Pdx-1 mRNA expression or 
immunoreactivity, or in Pax 4 mRNA expression.
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(viii) Weanlings exposed to a maternal HFD throughout both gestation and 
lactation (Group 14)
Exposure to a maternal HFD throughout both gestation and weaning seemed to 
have little effect on the blood glucose concentration, but did reduce the serum 
insulin levels significantly in weanling rats. GLUT-2 mRNA levels were 
significantly reduced, but there was a significant increase in GLUT-2 
immunoreactivity. It therefore appears that these pups are trying to increase 
insulin secretion by producing more GLUT-2 protein, thereby not only clearing 
glucose from the circulation, but also transporting more glucose into the beta-cell 
for metabolism. GK mRNA expression and immunoreactivity, however, were both 
significantly reduced. Therefore the rate of glycolysis would be reduced which 
may contribute to the hypoinsulinaemia. Although Pdx-1 mRNA was significantly 
overexpressed (highest amongst all of the groups), Pdx-1 immunoreactivity 
remained unaltered.
Pax 4 mRNA maintained normal expression levels. The effects of the HFD on 
islet cell development, as well as on Pax 4 protein expression, needs to be 
elucidated in future studies. It appears that the animal has managed to adapt to a 
HFD i.e. it has been programmed in utero to respond to a HFD. 
Hypoinsulinaemia is already evident in these offspring and the HFD has 
promoted a weight gain which would contribute to the development of obesity 
and insulin resistance. We postulate that if animals were to be maintained on a
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HFD until and during adulthood, they may eventually reach a point of saturation 
where hyperglycaemia becomes manifested.
(ix) Weanlings exposed to a maternal HFD throughout lactation (Group 15)
Pups that were exposed to a standard laboratory diet throughout pregnancy, then 
to a HFD throughout lactation were hyperglycaemic with normal circulating 
insulin concentrations at 3 weeks of age. GLUT-2 mRNA expression was 
reduced, with higher immunoreactivity, both significant changes. Although GK 
mRNA was significantly underexpressed, immunoreactivity for GK was normal. 
HFD exposure only for the duration of lactation was sufficient to induce 
hyperglycaemia in these offspring. Again, as in the previous groups that were 
exposed to a maternal HFD during pregnancy and for defined periods of 
weaning, the GLUT-2 overexpression at protein level does not seem to be 
adequate and cannot restore glucose homeostasis. Similar to GK, Pdx-1 mRNA 
expression was significantly lower, but immunoreactivity was normal. This 
suggests that reduced Pdx-1 transcription may have resulted in both the 
reduction of GLUT-2 and GK mRNA, as Pdx-1 is a key regulator of expression of 
these genes. Pax 4 mRNA was also significantly underexpressed and was lowest 
amongst the groups. It would be interesting to determine whether islet cell 
development is compromised in these offspring, as two of their key transcription 
factors were downregulated at mRNA level.
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Hyperglycaemia, hypoinsulinaemia, reduced expression of GK mRNA and 
immunoreactivity all occurred in weanling rats that were exposed to a maternal 
HFD for either the first (Group 6), or second (Group 7) or third (Group 8) week of 
gestation. Exposure to the HFD during these critical periods of pancreatic 
development resulted in low circulating insulin levels that appear to be unable to 
counteract the hyperglycaemia.
Glucose utilization results in insulin release from the beta-cell which stimulates 
the uptake of glucose into the peripheral tissues thereby maintaining glucose 
homeostasis. These raised glucose levels were accompanied by relatively 
normal GLUT-2 immunoreactivity but low insulin levels in Group 6, Group 7 and 
Group 8 weanlings. This suggests that, although glucose transport may be 
adequate, some component of GSIS is compromised. This is supported by 
another study where the plasma insulin concentrations were lower, in adult rats 
fed a HFD, and the glucose levels were higher when compared to those on a 
high carbohydrate diet (34). Impaired expression of GLUT-2 may impair glucose 
sensing and result in hyperglycaemia (103). However, in these groups, the 
GLUT-2 immunoreactivity was normal, but hyperglycaemia persisted, suggesting 
that the plasma insulin levels are insufficient to stimulate glucose uptake into the 
peripheral tissues.
4.9 Summary of the effects of exposure to a HFD in utero and during
lactation on GSIS in weanling rats
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In female Sprague-Dawley rats, fed a HFD (58% energy as fat) for 8 weeks, the 
body weight, insulin levels and triglycerides increased significantly (182). A 
longer term HFD induces a progressive impairment of insulin secretion in vivo 
(182). Furthermore, FFA are known to stimulate insulin secretion on a short-term 
basis (128) or inhibit insulin secretion on a long-term basis (183). The impairment 
of both insulin gene expression and insulin secretion suggests that a HFD is 
strongly diabetogenic in rodents (182). In our study, weanlings that had 
maximum exposure to a maternal HFD (Group 14) had significantly reduced 
circulating insulin concentrations, which may be due to a reduction in insulin 
gene expression. This appears to occur via a Pdx-1 independent mechanism as 
Pdx-1 immunoreactivity was normal in these offspring. It is also possible that FFA 
derived from the metabolism of the HFD may have inhibited insulin secretion. 
The mechanism appears to be via reduced expression of the glycolytic enzyme, 
GK.
An extensive study on yeast, which examined the relationship between yeast 
protein and message levels, revealed that the transcript levels provide little 
predictive value with respect to the extent of protein expression (184). The 
authors speculated that there was no predictive correlation between steady-state 
levels of mRNA and those of protein in mammalian cells (184). Similarly, we do 
not find a correlation in GLUT-2 mRNA and protein expression 
(immunoreactivity) in most of the weanling rats used in this study. GLUT-2 mRNA 
was significantly underexpressed, but in contrast, immunoreactivity for GLUT-2
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was significantly increased in some of the weanling groups. It therefore appears 
that the HFD exposure inhibits transcription of the GLUT-2 gene but stimulates 
the translation of GLUT-2 into protein.
A HFD in utero and/or during lactation resulted in significant differences in the 
circulating glucose and insulin concentrations and in the expression of the 
glucose sensing genes, GLUT-2 and GK. This suggests that metabolic changes 
are taking place, enabling the animal to physiologically adapt in order to restore 
glucose homeostasis in response to the HFD.
Pdx-1 mRNA expression and immunoreactivity were relatively normal in most of 
the weanlings, the only significance detected at mRNA level, in those exposed to 
the HFD for the third week of gestation (increased in Group 8), throughout both 
gestation and lactation (increased in Group 14) or throughout lactation (reduced 
in Group 15). Therefore Pdx-1 expression in most of these weanlings does not 
appear to be markedly changed by the HFD. The changes in the expression 
levels of GLUT-2 and GK therefore seem to be altered by the HFD in a Pdx-1- 
independent manner. Pax 4 mRNA was significantly reduced in weaned rats 
exposed to a HFD for the first (Group 6) or third (Group 8) week of gestation, 
throughout gestation only (Group 9) or throughout lactation only (Group 15). The 
reduction in Pax 4 mRNA appears to have contributed to the smaller alpha-cells 
in Group 6 and Group 8 weanlings. The reduced mRNA expression levels of the
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Pdx-1 and Pax 4 genes, in Group 15 weanlings, may inhibit the development and 
maturation of the islet cells. This needs to be investigated further.
Hyperglycaemia is the clinical hallmark of Type 2 diabetes. Furthermore, reduced 
expression of the glucose sensing genes, GLUT-2 and GK, would inhibit glucose 
transport and glycolysis, respectively, in the beta-cell. This, in turn, would limit 
insulin secretion from the beta-cell. Therefore, in offspring characterized by these 
conditions, beta-cell failure may eventually develop. Therefore it is important to 
monitor these changes in transcription factor and glucose sensing gene 
expression, as the animal ages. A HFD is known to decrease expression of Pdx- 
1, GLUT-2 and GK and promote weight gain in adult rats (34; 105; 135). This has 
been shown in some of the weanlings used in this study, and together with aging, 
will make these offspring prime candidates for the development of Type 2 
diabetes. However, the pancreas has the ability to adapt to increased metabolic 
needs in terms of increased insulin demand that occurs during pregnancy, aging, 
high fat feeding and diabetes (or hyperglycaemia). Furthermore, a significant 
reduction in beta-cell mass is not sufficient to induce diabetes due to the great 
reserve of the pancreas. But with time, the pancreas may be exhausted by the 
great demand for insulin, which could occur by continuous high fat feeding and 
this would subsequently lead to Type 2 diabetes.
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4.10 Summary of the effects of exposure to a HFD in utero and during 
lactation on islet cell development in weanling rats
Weanling rats exposed to a maternal HFD for either the first (Group 6), or second 
(Group 7) or third (Group 8) week of gestation had significantly fewer beta-cells 
which were also smaller. This compromisation in beta-cell development would 
inhibit beta-cell function, the main one being the maintenance of glucose 
homeostasis. The hypoinsulinaemia which occurred in these offspring appeared 
to play a role in the hyperglycaemia that was evident. In addition, these offspring 
exhibited reduced expression for GK (both mRNA expression and 
immunoreactivity), suggesting a reduced rate of glycolysis in the beta-cell. This 
would contribute to reduced insulin secretion and hypoinsulinaemia. 
Furthermore, significantly smaller alpha-cells were found in these offspring. Apart 
from in utero HFD exposure, Pax 4 also appears to have played a role in the 
small alpha-cell sizes, as the mRNA expression of this transcription factor was 
reduced significantly in Group 6 and Group 8 weanlings.
In weanlings exposed to a maternal HFD throughout gestation (Group 9 
weanlings), both beta-cell and alpha-cell development appeared to be normal. 
Although Pax 4 mRNA was significantly underexpressed, it did not affect islet cell 
development. Pdx-1 expression, at both mRNA and immunoreactive levels, were 
similar to the control levels, and appeared to be adequate to ensure normal 
development of both the beta- and alpha-cells.
p
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No data is available yet on the effects of a HFD on islet cell development in the 
offspring that had dietary insult in utero and/or during specific periods of lactation 
(Groups 11-15). This will be explored in further studies. Since the corresponding 
pancreatic weights are available, we shall be able to determine the beta-cell and 
alpha-mass in these offspring, in addition to the other parameters of islet cell 
development that were studied in the other groups.
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Groups were done in parallel, with some offspring euthanased at birth (postnatal 
day 1) after exposure to a HFD in utero, and other groups, that had the same 
exposure to a HFD in utero, monitored after weaning (3 weeks of age). This 
allowed us to detect any changes or adaptations that may have occurred in these 
offspring.
In neonatal rats, we showed that exposure to an in utero HFD for only the first 
week of gestation resulted in low birth weight (Group 1 neonates). Group 6 
weanlings had identical HFD exposure to Group 1 neonates, and were exposed 
to standard laboratory diet for the duration of weaning. At weaning, Group 6 
weanlings were also leaner. The other weanlings that were exposed to a 
maternal HFD during gestation, then to a standard laboratory diet during 
weaning, had normal birth weights (Group 2, Group 3 and Group 4 neonates), 
but had reduced body weights at 3 weeks of age (Group 7, Group 8 and Group 9 
weanlings). In contrast, offspring that were exposed to a maternal HFD 
throughout both gestation and weaning (Group 14 weanlings), which normal birth 
weights (Group 4 neonates), were significantly heavier at 3 weeks of age. Our 
data indicate that dams consumed more food when fed a HFD. This suggests 
that exposure to the maternal HFD during lactation resulted in a significant 
weight gain in Group 14 weanlings. The exposure of these weanling rats to the 
increased amount of fat from the HFD would contribute to the body weight gain.
Neonates and weanlings
4.11 Weights of offspring at birth and 3 weeks of age
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These rats may be prone to become obese later in life, which would make them 
prime candidates to develop Type 2 diabetes.
4.12 The effect of a maternal HFD on the circulating glucose and insulin 
concentrations in neonatal and weanling rats in relation to the expression 
of the transcription factor, Pdx-1, and glucose sensing genes, GLUT-2 and 
GK
Although changes in the serum insulin concentrations in pups that were exposed 
to an in utero HFD were detected at birth, these were not significant. However, 
hypoinsulinaemia was evident in these pups at 3 weeks of age. This reduction in 
the circulating insulin levels appeared to be responsible for the hyperglycaemia 
that was evident in weanlings that were exposed to a maternal HFD for the first, 
or second or third week of gestation. In order to understand why the circulating 
insulin levels had been reduced, we needed to examine the expression levels of 
the genes involved in GSIS, GLUT-2 and GK, and also Pdx-1, which is the 
transcription factor that not only regulates insulin gene transcription, but is also 
reported to regulate GLUT-2 and GK gene expression.
(i) Group 1 neonates and Group 6 weanlings
Hypoglycaemia was evident at birth in offspring that were exposed to a maternal 
HFD for only the first week of gestation but, between birth and weaning, these 
pups had already developed hyperglycaemia. Their reduced (though not 
significant) insulin levels at birth had become significantly reduced at 3 weeks of
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age. The expression of GLUT-2 mRNA, which was normal at birth, was 
significantly reduced once they reached weaning. Furthermore, the GK mRNA 
levels were significantly reduced both at birth and weaning, but the Pdx-1 mRNA 
levels remained normal at both birth and weaning. Both Pdx-1 and GLUT-2 
immunoreactivity were normal at birth and weaning, but GK immunoreactivity, 
which was significantly overexpressed at birth, was significantly underexpressed 
at weaning.
The change in the circulating glucose levels, that were significantly low at birth 
then significantly high at weaning, can be attributed to the GLUT-2 mRNA levels 
which were normal at birth but reduced significantly by the time the pups were 
weaned. Meanwhile, GK mRNA expression was also significantly reduced at 
birth and remained underexpressed at weaning, while GK immunoreactivity was 
significantly overexpressed at birth but significantly reduced at weaning. 
Underexpression of the glucose sensing genes, GLUT-2 (at mRNA level) and GK 
(both mRNA expression and immunoreactivity) seem therefore to have been the 
cause of these offspring developing hyperglycaemia at weaning. The reduced 
circulating insulin levels may be due to the significant underexpression of GLUT- 
2 and GK mRNA and the significant reduction of GK immunoreactivity, limiting 
the rate of glycolysis within the beta-cell. We speculate that all of these changes 
occur because GSIS is compromised. Pdx-1 mRNA expression and 
immunoreactivity was normal, and therefore does not seem to play a role in the 
hypoinsulinaemia evident in Group 6 weanlings.
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In offspring that were exposed to an in utero HFD for the second week of 
gestation, the hypoglycaemia at birth changed to hyperglycaemia at weaning 
while low circulating insulin levels deteriorated even further. In these offspring, 
GLUT-2 mRNA levels were reduced at birth and weaning, though not 
significantly; GK mRNA expression was normal at birth but significantly reduced 
at 3 weeks of age; Pdx-1 mRNA was normal both at birth and weaning while 
Pdx-1 immunoreactivity was significantly reduced at birth but increased to normal 
levels at weaning. GLUT-2 immunoreactivity was normal at birth and weaning 
and GK immunoreactivity was normal at birth but significantly reduced at 
weaning. From this we speculate that the development of hyperglycaemia and 
the deteriorating insulin levels in these offspring at weaning may be attributed to 
the significantly reduced GK mRNA expression and immunoreactivity which 
would impair glycolysis and GSIS. The hypoinsulinaemia would lead to 
hyperglycaemia because of the reduced availability of insulin to stimulate glucose 
uptake into peripheral tissues. It is possible that the very low, though not 
significant, GLUT-2 mRNA levels that were evident both at birth and weaning 
may contribute to the hyperglycaemia by reduced transport of glucose into the 
beta-cell for metabolism. The effect of the reduced GK immunoreactivity would 
be to limit the metabolism of glucose within the beta-cell. However, Pdx-1 
immunoreactivity, which was reduced at birth, had increased to normal levels in 
these pups at weaning possibly to increase transcription of the GK and insulin
(ii) Group 2 neonates and Group 7 weanlings
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genes in order to restore glucose homeostasis and the insulin levels to within the 
normal range.
(iii) Group 3 neonates and Group 8 weanlings
In offspring that were exposed to a maternal HFD for the third week of gestation, 
the normal circulating glucose and insulin levels measured at birth had 
deteriorated at weaning into hyperglycaemia and hypoinsulinaemia respectively. 
GLUT-2 mRNA expression was normal at birth and weaning. Pdx-1 mRNA 
expression was normal at birth, but was significantly higher at weaning, while 
GLUT-2 immunoreactivity appeared normal at birth but was significantly higher at 
weaning. Both GK mRNA expression and immunoreactivity were normal at birth 
but reduced significantly at weaning, while Pdx-1 immunoreactivity was normal at 
both birth and weaning.
It appears that GLUT-2 protein (as determined by image analysis) was 
overexpressed in these weanlings in an attempt to increase the rate of glucose 
transport into the beta-cell for metabolism. Pdx-1 mRNA was also 
overexpressed, suggesting that these offspring may be trying to increase protein 
expression of Pdx-1 as this important transcription factor has been reported to 
regulate the GLUT-2, GK and insulin gene expression. Although Pdx-1 mRNA 
levels were overexpressed, the increase in functional Pdx-1 protein, that would 
be required to increase transcription of the GK gene, did not occur. The levels of 
immunoreactive GLUT-2 protein had already been increased in response to the
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hyperglycaemia and hypoinsulinaemia, for improved glucose clearance from the 
circulation for metabolism within the beta-cell. However, the reduced GK 
immunoreactivity appears to compromise glycolysis and GSIS.
(iv) Group 4 neonates and Group 9 weanlings
In offspring that were exposed to an in utero HFD for the entire duration of 
pregnancy, hyperglycaemia, which was evident at birth, had been normalized at 
weaning. The normal insulin levels at birth, however, were significantly reduced 
in these pups at weaning. The restoration of hyperglycaemia to normal in these 
offspring at weaning can be attributed to the normal GK and Pdx-1 
immunoreactivity, which were both reduced at birth. This may be aided by the 
low GLUT-2 immunoreactivity (lowest amongst all of the groups) at birth being 
significantly increased at weaning, resulting in increased glucose transport into 
the beta-cell, and the restoration of glucose homeostasis. Because the glucose 
levels had been normalized at weaning, the mRNA expression and 
immunoreactivity for Pdx-1 and GK were normal despite the low circulating 
insulin levels. With hyperglycaemia at birth, both GK and Pdx-1 immunoreacitvity 
were significantly reduced, while normal glucose levels at weaning were 
accompanied by normal GK and Pdx-1 immunoreactivity. This could suggest that 
high blood glucose levels play a role in the modulation of both Pdx-1 and GK 
gene expression and it would be interesting to see whether expression of these 
genes is modulated as the animal matures.
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In offspring that were exposed to a maternal HFD throughout both gestation and 
weaning, hyperglycaemia at birth had normalized at weaning. The normal insulin 
levels at birth had decreased to hypoinsulinaemia at weaning. In these offspring, 
GLUT-2 immunoreactivity had been increased significantly between birth and 
weaning and this seems to be a sufficient compensatory mechanism at this 
stage, to restore glucose homeostasis. However, GLUT-2 mRNA had been 
significantly reduced, and the effect of this may soon impede the translation of 
GLUT-2 into protein. Additionally, the significant reduction in GK mRNA levels 
and immunoreactivity could result in a decrease in glycolysis in the beta-cell. 
With less glucose being metabolized in the beta-cell, less insulin will be secreted, 
and this may explain, in part, why the hypoinsulinaemia was evident in these 
weanling rats. Significantly higher Pdx-1 mRNA expression was detected in 
these offspring, with Pdx-1 immunoreactivity normal at weaning. Although the 
HFD may have a stimulatory effect on Pdx-1 mRNA expression (as these 
weanlings were exposed to a maternal HFD for their entire lives), we speculate 
that these animals may be attempting to increase protein synthesis of Pdx-1 in 
order to increase the expression levels of the GLUT-2, GK and insulin genes, 
therefore facilitating the maintenance of glucose homeostasis. The 
underexpression of GLUT-2 and GK mRNA may be associated with the 
hypoinsulinaemic status evident in these weanling rats.
(v) Group 4 neonates and Group 14 weanlings
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4.13 The effect of a maternal HFD on islet cell development in neonatal and 
weanling rats in relation to expression of Pdx-1 and Pax 4, transcription 
factors that are involved in islet cell development
(i) Group 1 neonates and Group 6 weanlings
In pups that were exposed to a maternal HFD for the first week of gestation, 
beta-cell volume was not significantly reduced, but the beta-cell number and size 
was significantly reduced, both at the neonatal and weanling stages of life. Pdx-1 
immunoreactivity was normal both at birth and weaning. However, Pax 4 mRNA, 
that was normal at birth, was significantly underexpressed at weaning. This may 
be responsible for inhibiting the development of the beta-cells, as Pax 4 is 
required for beta-cell maturation. These smaller beta-cells may be immature and 
therefore unable to secrete sufficient insulin, contributing to the hyperglycaemia 
in these pups at weaning. Pax 6 requires the expression of Pax 4 in order for 
alpha-cells to develop normally. The reduced Pax 4 mRNA expression may 
therefore account for the smaller alpha-cells. It is only by comprehensive 
recording of Pax 4 protein expression, and transcription factors associated with 
alpha-cell development, plus the circulating levels of glucagon secreted by the 
alpha-cells to increase glucose levels, that can one start to elucidate the 
mechanisms of all of the changes observed.
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(ii) Group 2 neonates and Group 7 weanlings
In offspring exposed to a maternal HFD for the second week of gestation, beta­
cell number and size, which appeared to be normal at birth, had significantly 
been reduced at weaning. The beta-cell volume, normal at birth, was also 
reduced at weaning, though not significantly. Alpha-cell size, which was larger at 
birth, had also been reduced significantly at weaning. The data indicate that 
these changes may be independent of Pdx-1 and Pax 4 expression as the 
profiles of these transcription factors were not significantly altered in weanling 
rats. The expression of other transcription factors involved in beta-cell 
maturation, such as Nkx 2.2 and Nkx 6.1 may have been altered by the HFD 
exposure during the second week of gestation. This needs to be investigated in 
further studies.
(iii) Group 3 neonates and Group 8 weanlings
In offspring exposed to a maternal HFD for the third week of gestation, there 
were significantly fewer beta-cells, at both birth and weaning, and normal beta­
cell sizes measured at birth were significantly reduced at weaning. In the 
weanlings, Pdx-1 mRNA expression, which was normal at birth, was significantly 
increased at weaning. This suggests that the offspring may be attempting to 
increase the low protein levels for Pdx-1 so that the beta-cells may develop and 
mature normally. However, the significant underexpression of Pax 4 mRNA may 
be the cause of both the compromised beta-cell development, and the reduced 
alpha-cell sizes in these weanlings. The reduced beta-cell size and number in
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these weanlings may be associated with the hyperglycaemia and 
hypoinsulinaemia in the weanlings as there would be reduced capacity for the 
beta-cells to secrete insulin in order to maintain glucose homeostasis.
(iv) Group 4 neonates and Group 9 weanlings
In pups that were exposed to a maternal HFD throughout gestation, the 
significantly reduced beta-cell volume and number at birth were all normalized at 
weaning. Elevated FFA have already been reported to contribute to the reduction 
in beta-cell mass that accompanies diabetes (54) and may well have played a 
role during gestation. After birth, the mothers were maintained on a standard 
laboratory diet and therefore ingested less food, and this appears to have 
contributed to the normalization of beta-cell development at weaning, which 
shows that the effect may be reversed by ingestion of a diet with a lower fat 
component. In order to understand how these changes occurred, we need to 
examine the data on Pdx-1 and Pax 4 expression. At birth, Pdx-1 
immunoreactivity was reduced and could be the cause of the compromised beta­
cell development, although other transcription factors involved in beta-cell 
development cannot be excluded. However, the almost significant increase in 
Pdx-1 mRNA levels in these neonates appears to have been an attempt to 
increase expression of Pdx-1 protein in order to correct and maintain normal 
beta-cell development. It is interesting that, once these pups have been weaned, 
normal expression of both Pdx-1 mRNA and protein occurred and the resultant 
normalization of beta-cell development in terms of volume, number and size was
166
Stellenbosch University http://scholar.sun.ac.za/
evident. This highlights the retained ability, at this stage, to initiate an adaptive 
response to correct the compromised beta-cell development that was evident at 
birth. Although hyperglycaemia existed in these offspring at birth, their blood 
glucose levels were restored to normal, at weaning, probably associated with the 
improved beta-cell development. However, hypoinsulinaemia, had developed by 
the time these pups were weaned, suggesting that, although beta-cell 
development may be adequate in these weanlings, the beta-cells may not be 
fully mature. This is supported by the significant underexpression of Pax 4 mRNA 
which is required for normal beta-cell maturation. As previously discussed, 
GLUT-2 immunoreactivity (protein expression levels) had been increased for 
increased glucose transport. The glucose- or lipid-infused rat model is used to 
study beta-cell mass and alterations in islet-specific gene expression, and an 
increase in insulin secretion at the renormalized glucose level was thought to be 
due to an increase in the catalytic rate of GK, GK being the rate limiting factor for 
glucose entry into the beta-cell (185; 186). However, no significant changes in GK 
mRNA expression and immunoreactivity were evident in Group 9 weanlings, and 
this may contribute to the hypoinsulinaemia. An increase in GK gene expression 
would increase the rate of glycolysis and therefore induce more GSIS which may 
return the circulating insulin levels to normal.
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4.14 The effects of maternal HFD exposure during lactation on glucose 
sensing genes in 3-week-old weanling rats (Group 9 and Group 14)
A comparison of groups of weanling rats, exposed to a maternal HFD throughout 
pregnancy, followed by a standard laboratory diet (Group 9) or a HFD (Group 14) 
for the duration of lactation, showed that hyperglycaemia at birth had been 
normalized in both groups of weanlings, with hypoinsulinaemia, however, evident 
in both. Expression of GLUT-2 and GK mRNA were further reduced in Group 14 
weanlings, after continued exposure to a HFD during lactation, while the mRNA 
profiles of these glucose sensing genes remained normal in Group 9 weanlings 
that were exposed to a standard laboratory diet during weaning. Several studies 
have shown that HFD-induced obesity and insulin resistance in rodents can be 
improved by reducing dietary fat content (187-189). In rats, a reduction in dietary 
fat from 40% to 30% of total energy was reported to rapidly reverse insulin 
insensitivity, as determined by glucose tolerance (188). Another study done in 
rats showed an almost linear relationship between the amount of dietary fat and 
glucose, with a threshold between 30% and 40% energy provided as fat (189). In 
a recent study, insulin resistance was induced by high fat feeding for 20 weeks in 
male C57BL/6J mice (179). The mice were then fed a low fat diet or maintained 
on a HFD for a further 12 weeks (179). Glucose tolerance and insulin sensitivity 
improved more efficiently with low fat feeding (179). Low fat feeding resulted in a 
decrease in both plasma glucose and insulin levels (179). Plasma glucose levels 
were reduced to severely low levels in low fat-fed mice, resulting in severe 
hypoglycaemia (179). Our Group 9 weanlings were first exposed to a HFD (40%
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as energy) throughout gestation then to a low fat diet (10% as energy) for the 
duration of lactation. Within a 3 week period, glucose homeostasis was restored, 
which emphasizes the importance of low fat feeding particularly in early 
developmental stages. Moreover, it shows that the animals have the ability to 
restore glucose homeostasis once the HFD insult is eliminated, which may have 
practical applications for patients with Type 2 diabetes. The data show that 
exposure to a HFD during weaning has a deleterious effect on the glucose 
sensing genes, GLUT-2 and GK, at the level of mRNA transcription. This was 
demonstrated in Group 14 weanlings that were permanently exposed to a 
maternal HFD.
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CHAPTER 5
CONCLUSIONS, 
PERSPECTIVES 
AND FUTURE 
STUDIES
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5.1.1 Mothers
A HFD appeared more palatable and induced hyperphagia in pregnant dams. 
Dams fed a HFD throughout pregnancy were heavier after giving birth. In 
addition, high fat feeding in pregnant dams induced hyperglycaemia. High fat 
feeding therefore had a diabetogenic effect in pregnant dams.
5.1.2 Neonates
The leaner neonates, exposed to a HFD for the first week of gestation, may be 
susceptible to develop diabetes later in life. Exposure to a maternal HFD 
throughout gestation had the most adverse effect on beta-cell development in 
neonates which may be explained, in part, by the reduced Pdx-1 
immunoreactivity (Fig. 36). Furthermore, these neonates were hyperglycaemic 
contributed by impaired glycolysis as GK immunoreactivity was reduced. Of all 
the neonates studied these were the most susceptible to beta-cell failure in 
adulthood.
Conclusions
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Fig. 36 The effects of an in utero HFD on beta-cell development and 
function in neonatal rats
Neonates that were exposed to an in utero HFD throughout gestation (Group 4) 
were hyperglycaemic. The HFD exposure throughout gestation resulted in 
reduced immunoreactivity for Pdx-1, a transcription factor required for beta-cell 
development and maintenance. This reduction in Pdx-1 expression appears to 
have contributed to the compromised beta-cell development, evident by the 
reduction in both beta-cell volume and number in these neonates. Furthermore, 
Pdx-1 is reported to regulate the expression of the GK gene, therefore the 
reduced Pdx-1 levels may, concomitant with the HFD exposure in utero, be 
responsible for the reduced GK immunoreactivity. Hyperglycaemia ensues due to 
a decrease in the rate of glycolysis thereby causing low GSIS inadequate to 
maintain glucose homeostasis. Since Pdx-1 also regulates the expression of the 
insulin gene, it may be possible that the reduction of Pdx-1 results in reduced 
insulin gene expression. A HFD may, also, directly inhibit beta-cell development 
and reduce GK expression, thereby inducing hyperglycaemia.
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Weanlings that were only exposed to a HFD during defined periods of gestation 
were leaner, suggesting that the reduced maternal food intake may play a role as 
the dams were maintained on a standard laboratory diet for the duration of 
lactation. These weanlings were all hypoinsulinaemic, associated with 
hyperglycaemia in those exposed for only a single week of gestation. A reduction 
in both GK mRNA expression and immunoreactivity was evident in these 
weanlings therefore impairing glycolysis and, ultimately, insulin secretion. The 
low circulating insulin levels appear unable to stimulate glucose uptake in 
peripheral tissues therefore hyperglycaemia persisted. In addition, beta-cell 
number and size were both reduced, increasing the functional load for each beta­
cell and thus contributing to hyperglycaemia.
Weanlings that were exposed to a HFD throughout gestation and continued for a 
single week of lactation were hyperglycaemic which was also associated with 
reduced GK expression. Exposure to a maternal HFD, from conception until 
weaning, induced an increase in the weight of progeny at 3 weeks of age and 
was associated with adverse effects on the mRNA expression of glucose sensing 
genes (Fig. 37). In contrast, those offspring weaned on a standard laboratory diet 
were able to normalize the expression of the glucose sensing genes. This 
demonstrates the adverse effects of high fat feeding during lactation and its 
ability to modulate gene expression.
5.1.3 Weanlings
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Fig. 37 The effects of a maternal HFD on beta-cell function in weanling rats
Weanlings exposed to a maternal HFD throughout gestation and lactation (Group 
14) had reduced mRNA expression of both glucose sensing genes, GLUT-2 and 
GK. It appears that the rate of glycolysis within the beta-cell is adversely affected 
by the HFD resulting in reduced GSIS, and subsequently, hypoinsulinaemia 
ensues. Interestingly, GLUT-2 was overexpressed at protein level (as determined 
by image analysis) suggesting an adaptative response by which glucose 
homeostasis is being maintained in these weanlings.
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This highlights the importance of maternal nutrition during the early developing 
stages of life in progeny. Exposure to a maternal HFD in utero (and/or lactation) 
has adverse effects on the expression of beta-cell transcription factors, glucose 
sensing genes and islet cell development in some neonatal and weanling 
offspring which may predispose them to beta-cell failure and the development of 
Type 2 diabetes later in life.
5.2 Perspectives
This study has demonstrated the importance of maternal nutrition for normal 
development of the endocrine pancreas and for beta-cell function in young 
offspring. A HFD in utero was shown to have adverse effects inducing 
hyperglycaemia and hypoinsulinaemia in some of the offspring. Furthermore GK 
mRNA and immunoreactivity was reduced in most of the weanlings coupling the 
hypoinsulinaemia to the hyperglycaemia. Glucose sensing is the initial event of 
GSIS and it is therefore important that adequate expression of GLUT-2 and GK is 
maintained for ensuring optimal insulin secretion in response to glucose. GK is 
believed to play a more important in glucose sensing than GLUT-2, although both 
are required for normal beta-cell function. Therapeutic agents directed towards 
increasing beta-cell GK expression and activity, and therefore glycolysis, will 
improve insulin secretion thereby restoring glucose homeostasis patients with 
Type 2 diabetes.
174
Stellenbosch University http://scholar.sun.ac.za/
Since transcription factors play major roles in pancreatic development, the 
regulation of their expression is important for maintaining normal pancreatic 
development and beta-cell function. Studies that further our overall knowledge of 
the basic mechanisms involved in the generation of functional insulin-producing 
beta-cells, and the factors that adversely affect the process, could reveal the 
appropriate target sites for the development of pharmaceutical agents to ensure 
normal beta-cell development.
It is therefore important to maintain optimal expression profiles for Pdx-1, GLUT- 
2 and GK as these are key genes involved in beta-cell function (Fig. 38). Pdx-1, 
in particular, is an attractive target as it is involved in the maintenance of both 
beta-cell development and function, and is also reported to regulate the key beta­
cell genes, insulin, GLUT-2 and GK. Fortunately, some therapeutic agents that 
modulate expression of these beta-cell genes are already available or in 
development. The incretin, glucagon-like peptide-1 (GLP-1), which is in the final 
phases of pharmaceutical development, has been shown to upregulate Pdx-1 
expression (190; 191). In addition, improved GLUT-2, GK and insulin expression 
occurred after administration of GLP-1, in aged rats (192). Thiazolidinediones 
(TZDs) increase GLUT-2 gene expression (193), endogenous GK expression 
and GK enzymatic activity in beta-cell lines (194). Peroxisomal proliferator- 
activated receptor-y (PPAR-y) directly increases GK expression in beta-cells 
resulting in an increase in GK activity (194).
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Fig. 38 Therapeutic maintenance of beta-cell function by modulation 
of Pdx-1, GLUT-2 and GK expression
The reduced expression of the key beta-cell genes Pdx-1, GLUT-2 and GK 
(induced by the HFD) can be reversed by the modulation of their expression by 
therapeutic agents. Glucagon-like peptide-1 improves Pdx-1, GLUT-2 and GK 
expression. Thiazolidinediones (which car also improve GLUT-2 and GK 
expression) and GK activators increase GK activity and thereby glycolysis. These 
agents contribute to augmenting GSIS thereby restoring glucose homeostasis 
and maintaining normal beta-cell function. The discovery of novel agents that can 
regulate expression the Pdx-1 gene, and increase the glucose sensing ability of 
the beta-cell by modulating GLUT-2, and particularly, GK expression, are 
important for improving insulin secretion and beta-cell function in patients with 
Type 2 diabetes.
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PPAR-y regulates gene expression of glucose sensing apparatus thereby 
improving glucose sensing ability of beta-cells, contributing to the restoration of 
beta-cell function (193; 194). The recently discovered anti-diabetic agents, 
glucokinase activators (GKA) enhance insulin release by activating glucose 
metabolism (195).
A HFD has adverse effects on beta-cell genes and promotes obesity, both of 
which may ultimately lead to the development of Type 2 diabetes. Anti-obesity 
drugs, currently in development, are important as obesity is a major risk factor for 
insulin resistance and Type 2 diabetes. Early detection of pathological changes 
by monitoring beta-cell function in people with obesity can prevent the onset of 
Type 2 diabetes. Following a healthy lifestyle by reducing dietary fat intake 
(particularly saturated fat) would be an important step towards preventing the 
development of Type 2 diabetes in people displaying abnormal beta-cell function. 
Ways to ameliorate the HFD-induced attenuation of glucose sensing and insulin 
secretion are important for future research in Type 2 diabetes.
5.3 Future studies
Several of the findings in this thesis study can lead to further studies. These 
include:
• The effect of HFD in utero on other transcription factors involved in beta­
cell maintenance (e.g. Nkx 2.2, Hnf-1a) and in alpha-cell maintenance 
(e.g. Pax 6)
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• Determining the rates of insulin secretion in isolated islets from these 
offspring in response to glucose
• Measuring C-peptide to reflect beta-cell function
• Determining the effect of a HFD in utero on different components of GSIS 
(e.g. ATP production, the K At p -  and Ca2+-channels and intracellular Ca2+ 
concentration)
• The use of various therapeutic agents that modulate the expression of 
these key beta-cell genes thereby maintaining glucose homeostasis and 
restoring beta-cell function
• Repeating the study in near-term rat foetuses, adult rats, non-pregnant 
and pregnant dams and in Vervet monkeys
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ANNEXURE
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ANOVA one-way analysis of variance 
AMV Avian Myeloblastosis Virus 
APES aminopropyltriethoxysilane 
bp base pair
BSA bovine serum albumin
cDNA complementary deoxyribonucleic acid
DAB dimethylaminobenzaldehdye
dH20 distilled water
DNA deoxyribonucleic acid
dNTP deoxynucleotide triphosphate
EDTA ethylenediaminetetraacetic
e embryonic day (or day of gestation)
EtBr ethidium bromide
Foxa2 forkhead box A2
FFA free fatty acids
GK glucokinase
GLP-1 glucagon-like peptide-1
GSIS glucose-stimulated insulin secretion
GLUT-2 glucose transporter-2
Hnf hepatocyte nuclear factor
HFD high fat diet
HF/HP high fat/high protein
Abbreviations
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IGF-1R insulin-like growth factor-1 receptor
IL-6 interleukin-6
IR insulin receptor
IRS insulin receptor substrate
Km Michalis Menten constant
LPL lipoprotein lipase
MgCI2 magnesium chloride
mRNA messenger RNA
MODY maturity-onset diabetes of the young
n sample number
Na2 sodium
NeuroDI neurogenic differentiation 1 
NGS normal goat serum 
Nkx Nk homeobox protein
PAGE/HPLC Polyacrylamide gel electrophoresis/High performance liquid
chromatography
Pax paired domain homeobox
PBGD porphobilinogen deaminase
PCR polymerase chain reaction
Pdx-1 pancreatic duodenal homeobox-1
PPAR-y peroxisomal proliferator-activated receptor-gamma
RIA radio immunoassay
RNA ribonucleic acid
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RT room temperature
RT-PCR reverse transcriptase PCR
SEM standard error of the mean
TAE tris-acetate
Taq Taq polymerase
TNF-a tumor necrosis factor-alpha
TBS tris-buffered saline
TZDs thiazolidinediones
UV ultra-violet
WHO World Health Organization
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The period of gestation in the Wistar rat is 3 weeks and lactation also lasts for 3 
weeks. The weeks of gestation and/or lactation during which the dams were 
maintained on a HFD represent the periods of exposure of their offspring to a 
HFD. The experimental groups depicted in the table represent neonates (Groups 
1-4) and weanlings (Groups 6-9, 11-15) that were exposed to a maternal HFD for 
specific periods of gestation and/or lactation. The control groups are Group 5 for 
the neonates and Group 10 for the weanlings. These offspring were only 
exposed to a standard laboratory (control) diet. When not exposed to a HFD, for 
example, weeks 2 and 3 of Group 1, the pups were exposed to a standard 
laboratory diet. Group 1 and Group 6 had identical exposure to a maternal HFD 
in utero, i.e. for the first week of gestation, with neonates from Group 1 
terminated at birth and weanlings from Group 6 terminated at 3 weeks of age. 
This is the same for Groups 2-4 and Groups 7-9, respectively. The weanling 
Groups 11-14 were exposed to a maternal HFD throughout gestation and for 
specific weeks of lactation. Group 15 weanlings were only exposed to a maternal 
HFD throughout lactation.
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Tablel Experimental groups
Group Period of exposure to a maternal 
HFD or standard laboratory 
(control) diet during gestation
Period of exposure to a maternal 
HFD or standard laboratory 
(control) during weaning
1 HFD: First week
Control: Second and third week
Rats terminated at birth
2 HFD: Second week 
Control: First and third week
Rats terminated at birth
3 HFD: Third week
Control: First and second week
Rats terminated at birth
4 HFD throughout gestation Rats terminated at birth
5 Control diet throughout gestation Rats terminated at birth
6 HFD: First week Control diet throughout weaning
7 HFD: Second week Control diet throughout weaning
8 HFD: Third week Control diet throughout weaninq
9 HFD: Throughout Control diet throughout weaning
10 Control diet throughout gestation Control diet throughout weaninq
11 HFD: Throughout HFD: First week
12 HFD: Throughout HFD: Second week
13 HFD: Throughout HFD: Third week
14 HFD: Throughout HFD: Throughout
15 Control diet throughout gestation HFD: Throughout
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